UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
[X] Preliminary Proxy Statement
[ ] CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY
RULE 14a-6(e)(2))
[ ] Definitive Proxy Statement
[ ] Definitive Additional Materials
[ ] Soliciting Material Pursuant to Section 240.14a-12
United American Healthcare Corporation
--------------------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)
--------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (check the appropriate box):
[ ] No fee required.
[X] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
1) Title of each class of securities to which transaction applies:
--------------------------------------------------------------------------------
2) Aggregate number of securities to which transaction applies:
--------------------------------------------------------------------------------
3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
--------------------------------------------------------------------------------
4) Proposed maximum aggregate value of transaction:
$75,652,197
--------------------------------------------------------------------------------
5) Total fee paid:
$15,130.44
--------------------------------------------------------------------------------
[ ] Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
1) Amount Previously Paid:
--------------------------------------------------------------------------------
2) Form, Schedule or Registration Statement No.:
--------------------------------------------------------------------------------
3) Filing Party:
--------------------------------------------------------------------------------
4) Date Filed:
--------------------------------------------------------------------------------
PERSONS WHO POTENTIALLY ARE TO RESPOND TO THE COLLECTION OF INFORMATION
CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS A
CURRENTLY VALID OMB CONTROL NUMBER.
SEC 1913 (02-02)
(LOGO) UNITED AMERICAN
HEALTHCARE CORPORATION
NOTICE OF SPECIAL MEETING OF SHAREHOLDERS
To the Shareholders of United American Healthcare Corporation:
NOTICE IS HEREBY GIVEN that a Special Meeting of Shareholders of United
American Healthcare Corporation will be held on ______, 2008 at __:00
[a.m./p.m.], Eastern Time, at the Atheneum Suite Hotel, 1000 Brush Avenue,
Detroit, Michigan.
The purpose of the Special Meeting is to consider and act upon the
following proposal, and to transact such other business as may properly come
before the meeting or an adjournment thereof:
- to approve the Purchase Agreement dated as of March 24, 2008 among us,
our subsidiaries United American of Tennessee, Inc. and UAHC Health
Plan of Tennessee, Inc. ("UAHC Health Plan") and Molina Healthcare,
Inc. ("Molina") and all transactions contemplated therein (together
with the Purchase Agreement and a Shareholder Agreement referred to in
it, the "Transactions").
The Transactions will occur ONLY IF UAHC Health Plan receives at least one
contract pursuant to the proposal that it and Molina have jointly submitted to
apply for contracts with the Department of Finance and Administration of the
State of Tennessee, Bureau of TennCare, to provide managed care services in the
East and West Grand Regions of Tennessee. TennCare's announcement of the award
of the contracts is scheduled for April 22, 2008, with the signing of the
contracts scheduled to occur no later than May 9, 2008.
Additional information relating to these matters is set forth in the proxy
statement enclosed herewith, which should be read carefully and in its entirety.
The Transactions proposal has been carefully reviewed by the Board of Directors
of the Company, who believe the proposal is fair and in the best interests of
the shareholders and who unanimously recommend that you vote FOR the proposal.
Only shareholders of record at the close of business on March 21, 2008 will
be entitled to vote at the Special Meeting.
PLEASE VOTE YOUR SHARES PROMPTLY. YOUR VOTE IS EXTREMELY IMPORTANT,
REGARDLESS OF THE NUMBER OF SHARES YOU HOLD. WHETHER YOU PLAN TO ATTEND THE
MEETING OR NOT, PLEASE SIGN, DATE AND MAIL THE ENCLOSED PROXY CARD AS SOON AS
POSSIBLE IN THE ENVELOPE PROVIDED. IF YOU SEND IN YOUR PROXY CARD AND THEN
DECIDE TO ATTEND THE SPECIAL MEETING TO VOTE YOUR SHARES IN PERSON, YOU MAY
STILL DO SO. YOUR PROXY IS REVOCABLE IN ACCORDANCE WITH THE PROCEDURES SET FORTH
IN THE PROXY STATEMENT.
We appreciate your continued support.
Sincerely,
/s/ William C. Brooks
William C. Brooks,
Chairman, President and
Chief Executive Officer
__________, 2008
(LOGO) UNITED AMERICAN
HEALTHCARE CORPORATION
UNITED AMERICAN HEALTHCARE CORPORATION
300 RIVER PLACE, SUITE 4950
DETROIT, MICHIGAN 48207-5062
----------
PROXY STATEMENT
----------
INTRODUCTION
This proxy statement is provided in connection with the solicitation of
proxies by United American Healthcare Corporation (the "COMPANY"), for use at
the Special Meeting of Shareholders of the Company to be held on ______, 2008 at
__:00 [a.m./p.m.], Eastern Time, at the Atheneum Suite Hotel, 1000 Brush Avenue,
Detroit, Michigan, and any adjournments thereof, for the purposes set forth in
the accompanying Notice of Special Meeting of Shareholders. This proxy statement
and proxies in the enclosed form are first being sent to the Company's
shareholders on or about ______, 2008.
It is important that your shares be represented at the Special Meeting. The
proxy is solicited on behalf of our Board of Directors. Shares represented by
valid proxies in the enclosed form will be voted if received in time for the
meeting. Whether you plan to attend the meeting or not, please sign, date and
mail the enclosed proxy card as soon as possible in the envelope provided. If
you send in your proxy card and then decide to attend the Special Meeting to
vote your shares in person, you may still do so. Your proxy is revocable in
accordance with the procedures set forth in this proxy statement.
The proposed sale to Molina Healthcare, Inc. of a 19.9% or 49.9% interest
in the stock of our subsidiary, UAHC Health Plan of Tennessee, Inc., the signing
of the Shareholder Agreement to be entered into with Molina, and the future sale
for cash to Molina, at its option, of our remaining UAHC Health Plan stock have
been agreed to in a Purchase Agreement between the Company and Molina in
connection with the proposal they jointly submitted to apply for one or two
TennCare managed care contracts. The closing of these and other transactions
contemplated in the Purchase Agreement are conditioned upon, among other things,
approval of the proposal stated in the Notice of Special Meeting of Shareholders
accompanying this proxy statement by a majority of the votes cast by the
Company's shareholders entitled to vote at the Special Meeting (represented in
person or by proxy).
If Molina would exercise its purchase option and if, consequently, the sale
of all our UAHC Health Plan stock is completed, the Company will sell
substantially all of its non-cash assets to Molina for the purchase price
determined as set forth in the Shareholder Agreement at some future time. THE
SHAREHOLDERS WILL NOT KNOW, AT THE TIME OF THE SPECIAL MEETING, THE ACTUAL
AMOUNT OF THE PURCHASE PRICE. HOWEVER, THE BOARD OF DIRECTORS OF THE COMPANY HAS
CAREFULLY REVIEWED AND APPROVED THE PROPOSAL AS BEING FAIR AND IN THE BEST
INTERESTS OF THE SHAREHOLDERS AND UNANIMOUSLY RECOMMENDS THAT YOU VOTE FOR THE
PROPOSAL.
1
NEITHER THE GRANTING OF MOLINA'S PURCHASE OPTION NOR THE SALES OF UAHC
HEALTH PLAN STOCK TO MOLINA HAVE BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
AND EXCHANGE COMMISSION, AND THE COMMISSION HAS NOT PASSED UPON THE FAIRNESS OR
MERITS OF SUCH TRANSACTIONS OR UPON THE ACCURACY OR ADEQUACY OF THE INFORMATION
CONTAINED IN THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.
SUMMARY TERM SHEET
The following is a summary of the most material terms of the signed
Purchase Agreement dated as of March 24, 2008 (attached to this proxy statement
as APPENDIX A) and the transactions contemplated therein, including a summary of
the most material terms of the proposed Shareholder Agreement which is Exhibit D
in such APPENDIX A. We have included page references in parentheses to direct
you to a more complete description of such transactions and agreements elsewhere
in this proxy statement.
- PARTIES. (See pages 13 and 14) The parties to the Purchase Agreement are
Molina Healthcare, Inc., UAHC Health Plan of Tennessee, Inc., United
American of Tennessee, Inc. and United American Healthcare Corporation. In
addition, if the proposal that UAHC Health Plan of Tennessee, Inc. and
Molina Healthcare, Inc. jointly submitted to TennCare in March 2008
results in receiving one or two TennCare contracts, and if applicable
conditions are satisfied or waived, then the Shareholder Agreement will be
entered into by UAHC Health Plan of Tennessee, Inc., United American of
Tennessee, Inc. and Molina Healthcare, Inc.
- DEFINED TERMS FOR BREVITY. For brevity in this proxy statement: (A) "WE" or
"OUR" refer to United American Healthcare Corporation; (B) our wholly-owned
subsidiary, UAHC Health Plan of Tennessee, Inc., is sometimes referred to
as "UAHC HEALTH PLAN"; (C) our wholly-owned subsidiary, United American of
Tennessee, Inc., is sometimes referred to as "UAT"; (D) Molina Healthcare,
Inc. is sometimes referred to as "MOLINA"; and (E) "SPECIAL MEETING" means
the Special Meeting of our shareholders referred to in the very first
paragraph of this proxy statement.
- THE SALE OF A MINORITY INTEREST IN OUR SUBSIDIARY. (See page 14) You are
being asked to approve the sale of a 19.9% or 49.9% stock interest in our
operating subsidiary, UAHC Health Plan, to Molina, depending on whether the
proposal they jointly submitted to TennCare in March 2008 results in
receiving one or two TennCare contracts, respectively. However, if no
TennCare contract is received pursuant to the joint proposal, there will be
no sale, and hence no Shareholder Agreement, and the Special Meeting will
be canceled.
- CLOSING OF THE MINORITY INTEREST SALE. (See page 14) The closing of the
sale of the minority stock interest to Molina will occur only if at least
one TennCare contract is received pursuant to the joint proposal. In that
event, the closing is expected to occur, if all applicable conditions have
been satisfied or waived, no sooner than the TennCare contract signing
(expected on or before May 9, 2008) and no later than the TennCare contract
effective date (expected to be November 1, 2008 if only a West Grand Region
contract is received, or January 1, 2009 if an East Grand Region contract
is received).
- CONSIDERATION FOR THE MINORITY INTEREST SALE. (See page 14) At the closing
(if any), the cash purchase price to be paid by Molina to UAHC Health Plan
will be $4,500,000 for a 19.9% interest, or $18,040,000 for a 49.9%
interest, in the total outstanding stock of UAHC Health Plan, as
applicable.
2
- MOLINA'S OPTION TO BUY-OUT OUR INTEREST IN UAHC HEALTH PLAN. (See pages
14-15) You are being asked to approve our granting Molina Healthcare, Inc.
an option to purchase all our shares of UAHC Health Plan stock for cash,
exercisable at a future time. Accordingly, you are being asked to approve
the sale of substantially all of our non-cash assets to Molina if it
exercises that option.(1) However, if no TennCare contract is received
pursuant to the joint proposal, there will be no such option, and hence no
such potential sale, and the Special Meeting will be canceled.
- WHEN MOLINA CAN EXERCISE ITS OPTION TO BUY-OUT OUR INTEREST IN UAHC HEALTH
PLAN. (See pages 14-15) Molina could exercise the option any time between
the dates that are 24 and 48 months (if the joint proposal results in one
TennCare contract) or 36 and 60 months (if it results in two TennCare
contracts) from the TennCare contract effective date. Accordingly, if the
joint proposal results in only a West Grand Region contract (with a
November 1, 2008 expected effective date), Molina could exercise the option
between November 1, 2010 and November 1, 2012; and if the joint proposal
results in a West Grand Region contract and an East Grand Region contract
(with a January 1, 2009 expected effective date), Molina could exercise the
option between January 1, 2012 and January 1, 2014.
- ALSO WHEN MOLINA CAN EXERCISE ITS OPTION TO BUY-OUT OUR INTEREST IN UAHC
HEALTH PLAN. (See page 15) In addition, Molina could exercise the option to
buy-out our interest in UAHC Health Plan prior to the expiration dates
described in the preceding paragraph any time that (i) UAHC Health Plan
requires a capital infusion of more than $5,000,000 upon a capital call by
its Board of Directors as set forth in the Shareholder Agreement, or
requires additional capital as mandated by TennCare and/or the Tennessee
Department of Commerce and Insurance, and (ii) UAT declines to contribute
its proportionate share, and (iii) Molina elects to and does contribute
100% of the required capital.
- CONSIDERATION FOR OUR ENTIRE INTEREST IN UAHC HEALTH PLAN. (See page 15) If
Molina exercises its option to purchase all of our UAHC Health Plan stock
(which is owned by our subsidiary, UAT), the cash purchase price to be paid
by Molina to UAT will equal the percentage share of all outstanding UAHC
Health Plan stock then owned by UAT multiplied by the Fair Market Value of
UAHC Health Plan determined as of the purchase closing date. For this
purpose, the Fair Market Value of UAHC Health Plan will equal the sum of
(1) its Medicaid membership multiplied by $345 per Medicaid member, plus
(2) its Medicare Advantage and/or Medicare Advantage Special Needs Plan
membership multiplied by $2,500 per Medicare member, plus (3) the market
value of its Medicare Advantage Prescription Drug Program plan business
operations, if any, plus (4) the sum of capital then held by UAHC Health
Plan in excess of its statutory minimum net worth requirement. Because
these variable components of the purchase price must be determined at an
indefinite date
----------
(1) We note that upon Molina's purchase of a minority interest in UAHC Health
Plan stock, the remaining majority interest in UAHC Health Plan stock that
UAT will continue to own will constitute substantially all of our non-cash
assets (i.e., assets other than cash, cash equivalents and marketable
securities), and may continue to constitute substantially all of our
non-cash assets when Molina later exercises its buy-out purchase option. It
is possible, however, that if and when Molina exercises the option, the
Company by that time might have acquired other non-cash assets to such an
extent that the sale of all of UAT's UAHC Health Plan stock to Molina would
not then be a sale of substantially all of our non-cash assets. Since that
is wholly speculative and may not occur, we ask shareholders to consider
and vote on the Transactions proposal at the Special Meeting (in person or
by proxy) on the assumption that if Molina exercises the option, the sale
of all of UAT's UAHC Health Plan stock to Molina would be a sale of
substantially all of our non-cash assets at that time.
3
likely to be more than 2 1/2 years from now, we cannot know or accurately
predict what the actual cash purchase price will be.
- OUR OPTION TO BUY ALL OF MOLINA'S INTEREST IN UAHC HEALTH PLAN. (See page
15) In the Shareholder Agreement, Molina will grant to our subsidiary, UAT,
the option to purchase all UAHC Health Plan stock owned by Molina for a
purchase price equal to the percentage share of the total outstanding UAHC
Health Plan stock then owned by Molina multiplied by the Fair Market Value
of UAHC Health Plan (as defined in the preceding paragraph) determined as
of the purchase closing date. UAT could exercise the option any time
between the dates that are 60 and 72 months from the effective date of the
TennCare contract received pursuant to the joint proposal. Accordingly, UAT
could exercise the option any time between November 1, 2013 and November 1,
2014 if the contract effective date for this purpose is November 1, 2008,
or between January 1, 2014 and January 1, 2015 if the contract effective
date for this purpose is January 1, 2009.
- MOLINA'S OPTION TO REQUIRE US TO BUY ALL OF ITS INTEREST IN UAHC HEALTH
PLAN. (See pages 15-16) In the Shareholder Agreement, our subsidiary, UAT,
will grant to Molina the option (called the "PUT") to require UAT to
purchase all UAHC Health Plan stock owned by Molina for a price equal to
the percentage share of the total outstanding UAHC Health Plan stock then
owned by Molina multiplied by the Total Value of UAHC Health Plan. Molina
could exercise the Put any time between the dates that are 60 and 72 months
from the effective date of the new TennCare contract. Accordingly, Molina
could exercise the Put any time between November 1, 2013 and November 1,
2014 if the contract effective date for this purpose is November 1, 2008,
or between January 1, 2014 and January 1, 2015 if the contract effective
date for this purpose is January 1, 2009. For this purpose, the Total Value
of UAHC Health Plan would be (i) the valuation proposed in writing by
Molina with its notice of exercising the Put, if agreed to by UAT, or (ii)
the alternative valuation proposed by UAT to Molina, or (iii) if Molina and
UAT could not agree upon the Total Value of UAHC Health Plan within 30 days
after Molina's notice of exercising the Put, the valuation determined by
arbitration procedures set forth in the Purchase Agreement.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This proxy statement contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act that are subject to the safe
harbor provisions created by that Act. Forward-looking statements can be
identified by the use of terms such as "expect," "could," "may," "believe,"
"anticipate," "will" and other future tense and forward-looking terminology.
Such forward-looking statements are based on management's current expectations
and involve known and unknown risks, uncertainties and other factors, many of
which the Company is unable to predict or control that may cause the actual
results, performance or achievements of the Company to be materially different
from any future results, performance or achievements expressed or implied by
such forward-looking statements.
ABOUT THE MEETING
WHAT IS THE PURPOSE OF THE SPECIAL MEETING?
At our Special Meeting, shareholders will act upon the proposal stated in
the Notice of Special Meeting of Shareholders accompanying this proxy statement,
to approve the Purchase Agreement dated as of March 24, 2008 among us, our
subsidiaries United American of Tennessee, Inc. and UAHC Health Plan of
Tennessee, Inc., and Molina Healthcare, Inc. and all transactions contemplated
therein (together with the Purchase Agreement and a Shareholder Agreement
referred to in it, the "TRANSACTIONS").
4
WHAT ARE THE BOARD'S RECOMMENDATIONS?
Unless you give other instructions on your proxy card, the persons named as
proxy holders on the proxy card will vote in accordance with the recommendation
of the Board of Directors of the Company (the "BOARD" or "BOARD OF DIRECTORS").
The Board's recommendation is set forth with the description of the Transactions
proposal in this proxy statement. In summary, the Board recommends a vote FOR
the approval of the Transactions proposal as being in the best interests of the
Company and our shareholders.
Management is not aware of any matters, other than as specified above, that
will be presented for action at the Special Meeting, but if any other matters do
properly come before the meeting, the proxy holders will vote as recommended by
the Board of Directors or, if no recommendation is given, at their discretion.
WHO IS ENTITLED TO VOTE AT THE MEETING?
Only shareholders of record at the close of business on March 21, 2008, the
record date for the meeting, are entitled to receive notice of and to
participate in the Special Meeting. If you were a shareholder of record on that
date, you will be entitled to vote all of the shares that you held on that date
at the meeting, or any postponements or adjournments of the meeting. As of the
record date, there were 8,734,214 shares of our Common Stock outstanding.
WHAT ARE THE VOTING RIGHTS OF HOLDERS OF THE COMPANY'S COMMON STOCK?
Under the Company's Articles of Incorporation, each holder of outstanding
Common Stock is entitled to cast one vote for each share of Common Stock held by
such holder.
WHO CAN ATTEND THE MEETING?
All shareholders as of the record date, or their duly appointed proxies,
may attend the meeting. If you attend, please note that cameras, recording
devices and other electronic devices will not be permitted at the meeting.
Please also note that if you hold your shares in "street name" (that is,
through a broker or other nominee), you will need to bring a copy of a brokerage
statement reflecting your stock ownership as of the record date in order to gain
entrance.
WHAT CONSTITUTES A QUORUM?
With respect to all of the matters to be voted on at the meeting, the
presence at the meeting, in person or by proxy, of the holders of a majority of
the shares of Common Stock outstanding on the record date will constitute a
quorum at the meeting, permitting the shareholders to take action on those
matters.
Proxies received but marked as abstentions and broker non-votes will be
included in the calculation of the number of votes considered to be present at
the meeting for purposes of determining a quorum.
HOW DO I VOTE?
If you complete and properly sign and date the accompanying proxy card and
return it to the Company, it will be voted as you direct. If you are a
registered shareholder and attend the meeting, you
5
may deliver your completed proxy card in person. "Street name" shareholders who
wish to vote at the meeting will need to obtain a proxy form from the
institution that holds their shares.
CAN I CHANGE MY VOTE AFTER I RETURN MY PROXY CARD?
Yes. Even after you have submitted your proxy, you may change your vote at
any time before the proxy is exercised by filing with the Secretary of the
Company either a notice of revocation or a duly exercised proxy bearing a later
date. In addition, the powers of the proxy holders will be suspended as to your
earlier submitted proxy if you attend the meeting in person and vote, although
attendance at the meeting will not by itself revoke a previously granted proxy.
WHAT VOTE IS REQUIRED TO APPROVE THE TRANSACTIONS PROPOSAL?
A majority of the votes cast by the shareholders of Common Stock entitled
to vote at the meeting (represented in person or by proxy) will be required to
approve the Transactions proposal. A properly executed proxy marked "ABSTAIN"
with respect to the Transactions proposal will not be voted, although it will be
counted for purposes of determining whether there is a quorum. Accordingly, an
abstention will have the effect of a negative vote.
If you hold your shares in "street name" through a broker or other nominee,
your broker or other nominee will not be permitted to exercise voting discretion
with respect to the Transactions proposal and may not be permitted to exercise
voting discretion with respect to any other matter that may properly come before
the meeting. Thus, if you do not give your broker or other nominee specific
instructions, your shares may not be voted on that proposal or those matters and
will not be counted in determining the number of shares necessary for approval.
Shares represented by such "broker non-votes" will, however, be counted in
determining whether there is a quorum.
WHAT WILL THE INSPECTOR OF ELECTION DO AT THE SPECIAL MEETING?
The shareholder votes cast for all items considered at the meeting will be
calculated by an officer of Computershare Investor Services, L.L.C., our
Registrar and Transfer Agent, as the Board-designated Inspector of Election. The
Inspector of Election will determine the number of shares outstanding and the
voting power of each, the shares represented at the meeting, the existence of a
quorum and the validity and effect of proxies, and shall receive votes, hear and
determine challenges and questions arising in connection with the right to vote,
count and tabulate votes, determine the result, and do such acts as are proper
to conduct the election. Abstentions will not be counted either for or against
any action for which cast.
WILL THE SHAREHOLDERS HAVE APPRAISAL RIGHTS OR SIMILAR RIGHTS OF DISSENTERS?
Under the Michigan Business Corporation Act, the shareholders of the
Company are not entitled to any appraisal rights or dissenters' rights in
connection with the Transactions or any other matter to be acted upon at the
Special Meeting.
WHAT IS BENEFICIAL OWNERSHIP?
Beneficial ownership has been determined in accordance with Rule 13d-3
under the Securities Exchange Act of 1934, as amended (the "EXCHANGE ACT").
Under Rule 13d-3, certain shares may be deemed to be beneficially owned by more
than one person (such as where persons share voting power or investment power).
In addition, shares are deemed to be beneficially owned by a person if the
person has the right to acquire the shares (for example, upon exercise of an
option) within 60 days of the date as of
6
which the information is provided. In computing the percentage of ownership of
any person, the amount of shares outstanding is deemed to include the amount of
shares beneficially owned by such person (and only such person) by reason of
such acquisition rights. As a result, the percentage of outstanding shares of
any person as shown on the following table does not necessarily reflect the
person's actual voting power at any particular time. The following information
is based on information contained in the most recent Schedule 13D or 13G and
Form 4 filings available to the Company.
HOW MUCH STOCK DO THE COMPANY'S 5% SHAREHOLDERS OWN?
The following table contains information with respect to the beneficial
ownership of our common shares as of March 21, 2008 by each person known by us
to beneficially own more than 5% of our common shares, our only outstanding
class of voting shares:
AMOUNT AND NATURE OF PERCENTAGE OF
NAME AND ADDRESS OF BENEFICIAL OWNER BENEFICIAL OWNERSHIP SHARES OWNED (1)
------------------------------------ -------------------- ----------------
Lloyd I. Miller, III 1,009,051(2) 11.6%
4550 Gordon Drive
Naples, FL 34102
Robert W. Morey and Maura Morey 662,196(3) 7.6%
1660 Tiburon Boulevard, Suite E
Tiburon, CA 94920
Bruce Galloway, Gary L. Herman, Strategic 625,428(4) 7.2%
Turnaround Equity Partners, L.P. (Cayman)
and Galloway Capital Management LLC
720 Fifth Avenue, 10th Floor
New York, NY 10019
Richard M. Brown, D.O. 470,949(5) 5.4%
1200 Ardmoor Drive
Bloomfield Hills, Michigan 48301
----------
(1) Based on 8,734,214 common shares outstanding as of March 21, 2008.
(2) The information with respect to Lloyd I. Miller, III, is based solely on
his Schedule 13G/A report (Amendment No. 1) filed January 3, 2008, his Form
4 report filed March 10, 2008, and a Schedule 13G/A report (Amendment No.
1) filed March 10, 2008 by The PNC Financial Services Group, Inc., PNC
Bancorp, Inc. and PNC Bank, National Association. Mr. Miller beneficially
owns an aggregate of 1,009,051 common shares, consisting of (i) 47,435
shares held by Mr. Miller for which he has sole voting and dispositive
power, (ii) 920,793 shares held in trust accounts as to which he and PNC
Bank, National Association, in its capacity as Trustee, share voting and
dispositive power, and 40,823 shares held by Milfam II L.P. as to which he
has sole voting and dispositive power. Mr. Miller disclaims beneficial
ownership of the shares described in clauses (ii) and (iii) above except to
the extent of his pecuniary interest therein.
(3) The information with respect to Robert W. Morey and Maura Morey is based
solely on a Schedule 13G/A report (Amendment No. 2) filed February 1, 2006.
They beneficially own an aggregate of 662,196 common shares, consisting of
(i) 227,241 shares held by Mr. Morey, (ii) 2,800 shares held by Mr. Morey
as custodian for his grandchild, Amberley Morey, and 900 shares held by Mr.
Morey as custodian for his grandchild, Elizabeth Gracey Morey, (iii) 12,000
shares held by Mr. Morey and Maura Morey as joint tenants and as to which
they share voting and dispositive power, and (iv) 419,255 shares held in
the RW Morey Defined Pension Trust for which Mr. Morey and Maura Morey
serve as co-trustees and as to which they share voting and dispositive
power.
(4) The information with respect to Bruce Galloway, Gary L. Herman, Strategic
Turnaround Equity Partners, L.P. (Cayman) and Galloway Capital Management
LLC is based solely on a Schedule 13D/A
7
(Amendment No. 2) report filed October 29, 2007. Strategic Turnaround
Equity Partners, L.P. (Cayman) is deemed to be the direct beneficial owner
of 451,684 common shares. Galloway Capital Management LLC, as the general
partner of Strategic Turnaround Equity Partners, L.P. (Cayman), is deemed
to be the indirect beneficial owner of 540,888 common shares. Bruce
Galloway and Gary L. Herman, as Managing Members of Galloway Capital
Management LLC, are deemed to be the indirect beneficial owners of 540,888
common shares. Each of Galloway Capital Management LLC, Bruce Galloway and
Gary L. Herman disclaims beneficial ownership of the common shares
beneficially owned by Strategic Turnaround Equity Partners, L.P. (Cayman)
(except for (i) the indirect interest of Galloway Capital Management LLC by
virtue of being the general partner of Strategic Turnaround Equity
Partners, L.P. (Cayman), (ii) the indirect interests of Bruce Galloway and
Gary L. Herman by virtue of being members of Galloway Capital Management
LLC, and (iii) the indirect interests of Bruce Galloway and Gary L. Herman
by virtue of being limited partners of Strategic Turnaround Equity
Partners, L.P. (Cayman). Galloway Capital Management LLC, Bruce Galloway
and Gary L. Herman have shared voting and dispositive power for these
common shares. Bruce Galloway also is the direct beneficial owner of 83,190
common shares, including 23,004 shares held by him, 25 shares owned by his
son for which Bruce Galloway has sole voting and dispositive power, 10,080
shares held by RexonGalloway Capital Growth, LLC, an investment company in
which Bruce Galloway is a member and for which he has full investment and
voting discretion, and 50,051 shares held by Jacombs Investments, Inc. for
which Bruce Galloway has full investment and voting discretion. Gary L.
Herman also is the direct beneficial owner of 1,350 common shares,
including 300 shares directly beneficially owned by him and 1,050 shares
held by FBR, Inc. for which he has sole voting and dispositive power.
(5) Including 25,000, 15,000, 15,000, 2,500, 2,834 and 8,750 shares which Dr.
Brown has the right to acquire pursuant to stock options that are
exercisable currently or become exercisable within 60 days after March 21,
2008 for a price of $5.08, $2.09, $4.27, $3.86, $4.73 and $1.90,
respectively.
HOW MUCH STOCK DO THE COMPANY'S NAMED EXECUTIVE OFFICERS AND DIRECTORS OWN?
The following table contains information with respect to the beneficial
ownership of our common shares as of March 21, 2008 by members of our management
team, which includes the current executive officers, our directors, and our
directors and executive officers as a group.
AGGREGATE NUMBER OF COMMON
SHARES BENEFICIALLY OWNED
---------------------------
NAME OF BENEFICIAL OWNER NUMBER (2) PERCENTAGE (1)
------------------------ ---------- --------------
EXECUTIVE OFFICERS
William C. Brooks 210,536 2.4%
Stephen D. Harris 126,099 1.4%
Stephanie Dowell 17,000 *
DIRECTORS (3)
Richard M. Brown, D.O. 470,949 5.4%
Darrel W. Francis 56,469 *
Tom A. Goss 98,441 *
Ronald E. Hall, Sr. 87,091 *
Emmett S. Moten, Jr. 97,162 *
Eddie R. Munson 34,497 *
All Directors and Executive
Officers as a group (9 persons) 1,198,244 13.7%
----------
* Represents less than 1% of the Company's outstanding common shares.
(1) Based on 8,734,214 common shares outstanding as of March 21, 2008. For
purposes of the table above, and in accordance with the rules of the SEC,
we deem common shares that are subject to options that are
8
currently exercisable or exercisable within 60 days of March 21, 2008 to be
outstanding and beneficially owned by the person holding the options for
the purpose of computing that person's percentage ownership, but we do not
treat them as outstanding in computing any other person's percentage
ownership.
(2) Includes the following number of common shares which the individual has the
right to acquire pursuant to stock options that are exercisable currently
or become exercisable within 60 days after March 21, 2008: Mr. Brooks,
149,084; Mr. Harris, 106,584; Ms. Dowell, 17,000; Dr. Brown and Mr. Hall,
69,084; Mr. Francis, 32,834; Mr. Goss, 47,834; Mr. Moten, 72,834; and Mr.
Munson, 25,000.
(3) Does not include William C. Brooks and Stephen D. Harris, who are also
executive officers and listed with the other executive officers in the
table above.
BUSINESS CONDUCTED BY THE COMPANY AND BY MOLINA
United American Healthcare Corporation (Nasdaq: UAHC) is a healthcare
management company headquartered in Detroit, Michigan. UAHC owns and manages
UAHC Health Plan, which is based in western Tennessee and includes the Memphis
market. UAHC Health Plan provides access to more than 900 primary and specialty
care physicians and more than 19 hospitals to the approximately 103,000 members
of UAHC Health Plan. UAHC Health Plan currently provides managed care services
on a modified-risk basis under an existing TennCare contract in the West Grand
Region of Tennessee, which is expected to end when the anticipated new TennCare
contracts for that Region, on a capitated, full-risk basis, become effective. In
addition, UAHC Health Plan is a Medicare Advantage qualified organization under
a contract with the Centers for Medicare & Medicaid Services, operating a
Medicare Advantage Special Needs Plan in Shelby County, Tennessee, and a
Voluntary Medicare Prescription Drug Plan. The Company's web site is
www.uahc.com; however, that information is not a part of this proxy statement.
Molina Healthcare, Inc. (NYSE: MOH) is a multi-state managed care
organization that arranges for the delivery of health care services to persons
eligible for Medicaid, Medicare, and other government-sponsored programs for
low-income families and individuals. Molina's nine licensed health plan
subsidiaries in California, Michigan, Missouri (under the Mercy CarePlus name),
Nevada, New Mexico, Ohio, Texas, Utah and Washington currently serve
approximately 1.1 million members. Molina's web site is
www.molinahealthcare.com; however, that information is not a part of this proxy
statement.
The mailing address and telephone number of our and Molina's principal
executive offices are shown below:
United American Healthcare Corporation
300 River Place, Suite 4950
Detroit, Michigan 48207-5062
(313) 393-4571
Molina Healthcare, Inc.
200 Oceangate, Suite 100
Long Beach, California 90802
(562) 435-3666
AVAILABLE INFORMATION
We file annual, quarterly and current reports, proxy statements and other
information with the SEC. You may read and copy any reports, proxy statements or
other information with the SEC at its Public Reference Room, 100 F Street, N.E.,
Washington, D.C. 20549. You may obtain information on the SEC's public reference
room in Washington, D.C. by calling the SEC at 1-800-SEC-0330. We file
information electronically with the SEC and these filings are available from the
SEC's Internet site at http://www.sec.gov, which contains reports, proxy and
information statements and other information regarding issuers that file
electronically. Our shares of common stock are listed on The Nasdaq Capital
Market under the symbol "UAHC." You may read and copy our SEC filings and other
information at the offices of Nasdaq Operations, 1735 K Street, N.W.,
Washington, D.C. 20006. Information about us,
9
including our SEC filings, is also available on our web site at
http://www.uahc.com; however, that information is not a part of this proxy
statement.
NO PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE ANY
REPRESENTATIONS OTHER THAN THOSE CONTAINED, OR INCORPORATED BY REFERENCE, IN
THIS PROXY STATEMENT IN CONNECTION WITH THE SOLICITATION OF PROXIES MADE HEREBY,
AND IF GIVEN OR MADE, SUCH INFORMATION OR REPRESENTATIONS SHOULD NOT BE RELIED
UPON AS HAVING BEEN AUTHORIZED BY THE COMPANY OR ANY OTHER PERSON. ALL
INFORMATION CONTAINED IN THIS PROXY STATEMENT RELATING TO MOLINA UNDER THE ABOVE
CAPTION "BUSINESS CONDUCTED BY THE COMPANY AND BY MOLINA" HAS BEEN SUPPLIED BY
MOLINA. THE DELIVERY OF THIS PROXY STATEMENT SHALL NOT, UNDER ANY CIRCUMSTANCES,
CREATE AN IMPLICATION THAT THERE HAS BEEN NO CHANGE IN THE AFFAIRS OF THE
COMPANY, UAHC HEALTH PLAN, UAT OR MOLINA SINCE THE DATE HEREOF OR THAT THE
INFORMATION HEREIN IS CORRECT AS OF ANY TIME SUBSEQUENT TO ITS DATE.
BACKGROUND OF THE TRANSACTIONS
In early 2007, the Company became aware that the State of Tennessee's
TennCare Bureau could issue a request for proposals for TennCare's East and West
Grand Regions (the "RFP") as early as later that year.
The Company's wholly-owned subsidiary, UAHC Health Plan, is an incumbent
contractor in the TennCare West Grand Region, with over 14 years' experience in
the TennCare system. The Company's management believes that the Company has a
well staffed operation in Memphis, Tennessee with an extensive provider network
consisting of more than 900 primary and specialty care physicians and more than
19 hospitals in Tennessee. However, the Company's management determined that, to
maximize its chances for success in the RFP process and to better serve the
members of UAHC Health Plan in the future, the Company should explore potential
strategic alliances or joint ventures with one or more national healthcare
management companies.
During the summer and fall of 2007, a team of the Company's senior
executives (reporting to the Company's Chairman and Chief Executive Officer,
William C. Brooks) identified several companies which in their judgment could
serve as suitable strategic partners for the Company. The Company's executives
and representatives had discussions with each of these candidates. The Company
was able to structure an acceptable arrangement with only one of them, Molina
Healthcare, Inc.
On September 10, 2007, an initial meeting was held in Detroit, Michigan,
between representatives of the Company and Molina, including Mr. Brooks and
Stephen D. Harris, the Company's Executive Vice President and Chief Financial
Officer, for the Company, and Marvin Cobern, Molina's Vice President for
Strategic Planning and Development. Following that meeting, a conference call
was held on September 17, 2007, to further discuss a potential strategic
alliance or joint venture between the companies. The participants in the
conference call included Messrs. Brooks and Harris for the Company and several
senior executives of Molina, including John C. Molina, Molina's Chief Financial
Officer. Following additional discussions between representatives of the two
companies, Molina and the Company entered into a Mutual Confidentiality and
Non-Disclosure Agreement dated as of October 1, 2007.
From October 4, 2007 through November 20, 2007, senior executives of the
Company held negotiations with Molina representatives regarding a joint venture
between the two companies. On behalf of the Company, these negotiations were led
by Messrs. Brooks and Harris. They were assisted by the
10
Company's financial advisor, The Chesapeake Group of New York City, and the
Company's principal law firm, Honigman Miller Schwartz and Cohn LLP.
On November 2, 2007, at its regular quarterly meeting, the Board of
Directors of the Company reviewed the status of the potential joint venture
between the Company and Molina. At the meeting, presentations were made by
senior executives of the Company and the Company's financial advisor and legal
counsel. Following these presentations, the Board unanimously voted to authorize
the Company to continue negotiating with Molina and to enter into a non-binding
preliminary agreement with Molina to establish a joint venture with respect to
health maintenance organization operations in Tennessee.
Discussions continued between representatives of the Company and Molina and
led, on November 20, 2007, to a preliminary agreement between them to establish
a joint venture. The agreement, titled "Memorandum of Interest and Exclusive
Negotiating Agreement," provided, among other things, that the parties would
"exclusively negotiate with each other" regarding submitting a joint response to
the anticipated RFP, and would continue to "expend the time, energy and
resources necessary to negotiate the acquisition [by Molina] of an equity
interest in [UAHC Health Plan]". Attached to the preliminary agreement was a
"preliminary term sheet," which proposed that (1) Molina acquire an equity
interest in UAHC Health Plan for a cash payment at the closing, and (2) Molina
acquire an option exercisable at a later date to purchase full ownership of UAHC
Health Plan at a formula price, with additional consideration for UAHC Health
Plan's Medicare Advantage business and any excess statutory net worth of UAHC
Health Plan at the time of such purchase.
On November 28, 2007, the Company's Board of Directors held a special
meeting to discuss the potential Molina joint venture. At the meeting, the Board
reviewed the terms of the November 20th preliminary agreement, including the
"preliminary term sheet" and unanimously ratified the Company's execution of the
preliminary agreement (including the preliminary term sheet). However, the Board
also directed the Company's management to make further presentations to the
Company's Board before entering into any definitive agreements relating to the
proposed Molina joint venture. The Board also directed its Finance and Audit
Committee to conduct further evaluation and inquiry regarding whether the
potential transaction with Molina was in the best interests of the Company and
its shareholders. The Finance and Audit Committee was asked to focus
particularly on whether the pricing was fair for both (a) the initial sale to
Molina of a minority equity interest in UAHC Health Plan and (b) a subsequent
sale to Molina of the Company's entire equity interest in UAHC Health Plan, in
the event Molina exercised its purchase option described in the November 20th
preliminary agreement. The Finance and Audit Committee was asked to make a
recommendation to the full Board regarding the proposed Molina joint venture
before the Board would vote on whether to authorize the Company to enter into
any definitive agreements for the proposed transaction.
From November 28, 2007 through December 22, 2007, the Finance and Audit
Committee of the Company's Board reviewed substantial information regarding
Molina, the Company's Tennessee operations, TennCare, and the terms of the
proposed Molina joint venture, including the proposed initial sale to Molina of
a minority equity interest in UAHC Health Plan and the terms of the buy-out
option proposed to be granted to Molina. In connection with its review, the
Committee held discussions with the Company's senior executives and, in
executive sessions, held discussions with the Company's financial advisor and
legal counsel regarding the proposed Molina joint venture.
Based on its review, the Finance and Audit Committee of the Company's Board
concluded that Molina represented a strong potential partner for the Company,
and that the proposed affiliation with Molina offered substantial advantages to
the Company in connection with both UAHC Health Plan's response to the
anticipated RFP and UAHC Health Plan's potential future operations in regard to
TennCare. Among other things, the Committee noted that the proposed affiliation
with Molina would
11
bring significant additional capability to the Company's Tennessee operations,
in the form of Molina's substantial knowledge and experience in behavioral
health and disease management.
The Finance and Audit Committee of the Company's Board also considered the
pricing of the proposed sale to Molina of a minority equity interest in UAHC
Health Plan and the purchase price to be paid by Molina in the event it
exercised the buy-out option proposed to be granted to it to purchase full
ownership of UAHC Health Plan. In its consideration of the pricing issues, the
Finance and Audit Committee took into account the current public trading price
of the Company's shares and the terms of comparable transactions involving sales
of health maintenance organizations. The Finance and Audit Committee also took
into account that, under the proposed structure for the joint venture with
Molina, following the initial closing Molina and its organization would be
required to make a significant contribution to UAHC Health Plan in terms of
operations and capital. In the Finance and Audit Committee's judgment, by making
such contributions Molina will therefore have substantially contributed to any
increased future value of UAHC Health Plan at the time of any exercise of the
Molina purchase option.
On December 22, 2007, the Company's Board of Directors held a special
meeting to discuss the proposed Molina joint venture. The Company's senior
executives and legal counsel were also in attendance. At the meeting, the
Chairman of the Finance and Audit Committee, Darrel W. Francis, described the
Committee's review of the proposed transaction and reported the Committee's
findings. Mr. Francis said that based on the Finance and Audit Committee's
review, the Committee determined that the joint venture with Molina was in the
best interests of the Company and its shareholders, and the Committee
unanimously recommended that the Board of Directors grant the Company's
management authority to complete negotiations with Molina and to enter into
definitive agreements consistent with the presentations that had been made to
the Board of Directors.
After further discussion, the Board of Directors unanimously voted to
authorize the Company's management to negotiate definitive agreements with
Molina for a joint RFP submission by Molina and UAHC Health Plan, for Molina's
investment in a minority stock interest in UAHC Health Plan and for the grant to
Molina of a purchase option for all of the Company's stock interest in UAHC
Health Plan, all on the terms presented to the Board. The Board also directed
the Company's management to present the terms of such definitive agreements to
the full Board of Directors prior to execution.
On January 7, 2008, the State of Tennessee's TennCare Bureau issued its
RFP. Representatives of UAHC Health Plan attended TennCare's Pre-Proposal
Conference on January 16, 2008. On January 23, 2008, UAHC Health Plan and Molina
filed with TennCare a joint Notice of Interest to Propose with respect to the
RFP. On March 11, 2008, UAHC Health Plan and Molina jointly filed a response to
the RFP. The response included their joint proposal to provide contracted
managed care services in both the TennCare West and East Grand Regions.
On March 13, 2008, at its regular quarterly meeting, the Board of Directors
of the Company reviewed the status of the Molina joint venture. Messrs. Brooks
and Harris and the Company's counsel, Alex L. Parrish, made presentations
regarding the RFP response process and the status of negotiations regarding the
definitive Molina joint venture agreements. Following these presentations and
further discussions among the Directors, the Board of Directors unanimously
authorized the Company's officers to complete negotiations with Molina regarding
the definitive joint venture agreements, including a Purchase Agreement and form
of Shareholder Agreement, and to enter into the same on behalf of the Company.
On March 20, 2008, the Board of Directors held another special meeting to
discuss the terms of the Molina transaction. At the meeting, with all Directors
present, Mr. Brooks and legal counsel reported
12
on the parties' most recent negotiations. Following discussion, the Board of
Directors unanimously voted: (A) to request the Chairman of the Board of
Directors of the Company to call a special meeting of the shareholders of the
Company, to consider and act upon a Company proposal to approve the Purchase
Agreement with Molina and all transactions contemplated therein, including
without limitation the sale to Molina of a minority equity interest in UAHC
Health Plan and the grant to Molina of an option, exercisable at a future date,
to purchase for cash all of the Company's shares of UAHC Health Plan stock; and
(B) to declare the Board's belief that such proposal is fair and in the best
interests of the shareholders and to recommend that the Company's shareholders
should vote for the proposal.
On March 24, 2008, the Company and Molina entered into a definitive
Purchase Agreement, and the Company publicly announced the joint venture with
Molina. Prior to executing the Purchase Agreement, the Company's Board of
Directors was briefed by the Company's senior executives and legal counsel that
morning by telephone on the last negotiation activity preceding completion of
the documents, and the Board of Directors then gave its final approval to the
Company's execution and delivery of the definitive agreement with Molina.
PROPOSAL: THE TRANSACTIONS
The Transactions are summarized below. This summary does not purport to be
complete and is qualified in its entirety by reference to the Purchase
Agreement, attached hereto as APPENDIX A (including without limitation the form
of Shareholder Agreement which is Exhibit D in APPENDIX A), which is
incorporated by reference herein. Shareholders are urged to read APPENDIX A to
this proxy statement in its entirety.
INTRODUCTION
On January 7, 2008, the Department of Finance and Administration of the
State of Tennessee, Bureau of TennCare ("TENNCARE"), issued a Request for
Proposals (as since amended, "RFP") for managed care services to be provided in
the East Grand Region and the West Grand Region of Tennessee. The RFP indicates
TennCare's intent to award two contracts in the East Grand Region and two
contracts in the West Grand Region. TennCare's award of the contracts is
scheduled for April 22, 2008, with the signing of the contracts scheduled to
occur no later than May 9, 2008. The performance of the contracts is expected to
start in the West Grand Region on November 1, 2008 and in the East Grand Region
on January 1, 2009. It is expected that each contract will require the
successful bidder to provide comprehensive medical services on a capitated,
full-risk basis to Medicaid beneficiaries assigned to it by TennCare in the
applicable Region.
In response to the RFP, on March 11, 2008, our subsidiary, UAHC Health Plan
of Tennessee, Inc. ("UAHC HEALTH PLAN"), and Molina Healthcare, Inc., a Delaware
corporation ("MOLINA"), jointly submitted a proposal to apply for contracts with
TennCare for both the East and West Grand Regions. The RFP proposal potentially
could result in UAHC Health Plan and Molina jointly receiving two TennCare
contracts (one for each Region), or one TennCare contract for one Region, or no
TennCare contract for either Region. UAHC Health Plan currently provides managed
care services on a modified-risk basis under an existing TennCare contract in
the West Grand Region only, which is expected to end when the anticipated new
TennCare contracts for that Region become effective.
In connection with the joint proposal, on March 24, 2008 we and our
subsidiaries, United American of Tennessee, Inc. and UAHC Health Plan, entered
into a Purchase Agreement with Molina dated as of March 24, 2008 (the "PURCHASE
AGREEMENT"). A copy of the Purchase Agreement is attached as APPENDIX A to this
proxy statement and incorporated herein by reference. We and our affiliates
13
have no relationship with Molina other than in respect of the Purchase
Agreement, any agreements contemplated by the Purchase Agreement and the joint
proposal.
DESCRIPTION OF THE PURCHASE AGREEMENT
Currently, our wholly-owned subsidiary, United American of Tennessee, Inc
("UAT"), owns 100% of the issued and outstanding stock of UAHC Health Plan.
Under the Purchase Agreement, if (AND ONLY IF) UAHC Health Plan enters into at
least one of the new TennCare contracts, Molina will become a part owner of UAHC
Health Plan by purchasing newly issued UAHC Health Plan stock from UAHC Health
Plan, either: (A) shares representing 19.9% of the total issued and outstanding
UAHC Health Plan stock, for a purchase price of $4,500,000, in the event UAHC
Health Plan executes one new TennCare contract; or (B) shares representing 49.9%
of the total issued and outstanding UAHC Health Plan stock, for a purchase price
of $18,040,000, in the event UAHC Health Plan executes two new TennCare
contracts. Our subsidiary UAT would continue to own all of the remaining
outstanding UAHC Health Plan stock. The Purchase Agreement requires the stock
purchase closing (the "CLOSING") to occur on a date mutually agreed upon by the
parties that is no earlier than the signing of the full-risk contract(s)
(currently expected to occur by May 9, 2008) and no later than the effective
date(s) of the contract(s) (currently expected to be November 1, 2008 for the
West Grand Region and January 1, 2009 for the East Grand Region), or on such
other date as the parties may mutually agree in writing.
The Purchase Agreement requires the delivery at the Closing of a
Shareholder Agreement among UAHC Health Plan and its shareholders, UAT and
Molina (the "SHAREHOLDER AGREEMENT"). The form of the Shareholder Agreement is
an exhibit to the Purchase Agreement. The Purchase Agreement also requires us to
seek approval from our shareholders of the Purchase Agreement and all
transactions contemplated in it (including without limitation Molina's Purchase
Option, as described below), and makes our obtaining that approval a condition
precedent to the Closing.
Thus, the reason for the Special Meeting of Shareholders to which this
proxy statement pertains is to obtain our shareholders' approval of the Purchase
Agreement and all transactions contemplated in it (together with the Purchase
Agreement and the Shareholder Agreement referred to in it, called the
"TRANSACTIONS" in this proxy statement). The Transactions proposal to be
considered and acted on at the Special Meeting has been carefully reviewed by
the Board of Directors of the Company, who believe the proposal is fair and in
the best interests of the shareholders and who unanimously recommend that you
vote FOR the proposal.
The Transactions will occur ONLY IF UAHC Health Plan receives at least one
contract pursuant to the RFP proposal that it and Molina jointly submitted in
March 2008 to apply for contracts with the Department of Finance and
Administration of the State of Tennessee, Bureau of TennCare, to provide managed
care services in the East and West Grand Regions of Tennessee. TennCare's
announcement of the award of the contracts is scheduled for April 22, 2008, with
the signing of the contracts scheduled to occur no later than May 9, 2008.
The Purchase Agreement may be terminated any time prior to the Closing by
mutual written consent of the parties and in certain other events.
DESCRIPTION OF THE SHAREHOLDER AGREEMENT
The Shareholder Agreement will be entered into at the Closing when Molina
becomes a minority shareholder of UAHC Health Plan. In the Shareholder
Agreement, if and when executed, our subsidiary UAT would grant Molina the
exclusive option to purchase all UAHC Health Plan stock owned by UAT, for a
purchase price described below ("MOLINA'S PURCHASE OPTION"). Molina could
exercise the option
14
any time between the dates that are 24 and 48 months (in the event UAHC Health
Plan executes one new TennCare contract) or 36 and 60 months (in the event UAHC
Health Plan executes two new TennCare contracts) from the effective date of the
new TennCare contract(s). Accordingly, if the joint proposal results in only a
West Grand Region contract (with a November 1, 2008 expected effective date),
Molina could exercise the option between November 1, 2010 and November 1, 2012;
and if the joint proposal results in a West Grand Region contract and an East
Grand Region contract (with an January 1, 2009 expected effective date), Molina
could exercise the option between January 1, 2012 and January 1, 2014.
In addition, Molina could exercise Molina's Purchase Option prior to the
expiration dates described in the preceding paragraph any time that (i) UAHC
Health Plan requires a capital infusion of more than $5,000,000 upon a capital
call by its Board of Directors as set forth in the Shareholder Agreement, or
UAHC Health Plan requires additional capital as mandated by TennCare and/or the
Tennessee Department of Commerce and Insurance, and (ii) UAT declines to
contribute its proportionate share, and (iii) Molina elects to and actually does
contribute 100% of the required capital.
Under the Shareholder Agreement, Molina's exercise of its option to
purchase all UAHC Health Plan stock owned by UAT would require it to pay UAT a
purchase price equal to the percentage share of UAHC Health Plan then owned by
UAT multiplied by the Fair Market Value of UAHC Health Plan determined as of the
closing date of the purchase. As used in the Shareholder Agreement, the "Fair
Market Value of UAHC Health Plan" is equal to the sum of (1) UAHC Health Plan's
Medicaid membership multiplied by $345 per Medicaid member, plus (2) UAHC Health
Plan's Medicare Advantage and/or Medicare Advantage Special Needs Plan
membership multiplied by $2,500 per Medicare member, plus (3) the market value
of any Medicare Advantage Prescription Drug Program plan business operations of
UAHC Health Plan, plus (4) the sum of capital then held by UAHC Health Plan in
excess of its statutory minimum net worth requirement.
The Shareholder Agreement provides that if the Company shareholders'
approval of the Transactions proposal (as stated in the Notice of Special
Meeting of Shareholders accompanying this proxy statement) is not obtained for
any reason and if that closing condition is waived by Molina, Molina's Purchase
Option shall be amended so that Molina will have an option to only acquire the
maximum number of UAT's shares of UAHC Health Plan stock that will permit UAT to
retain a significant continuing business activity as set forth under state and
federal statutes and regulations, and in that event the Transactions (including
the grant of Molina's Purchase Option) will not require shareholder approval.
Also in the Shareholder Agreement, Molina would grant UAT the exclusive
option to purchase all UAHC Health Plan stock owned by Molina, for a purchase
price equal to the percentage share of UAHC Health Plan then owned by Molina
multiplied by the above-defined Fair Market Value of UAHC Health Plan determined
as of the closing date of the purchase. UAT could exercise the option any time
between the dates that are 60 and 72 months from the effective date of the new
TennCare contract. Accordingly, UAT could exercise the option any time between
November 1, 2013 and November 1, 2014 if the contract effective date for this
purpose is November 1, 2008, or between January 1, 2014 and January 1, 2015 if
the contract effective date for this purpose is January 1, 2009.
Also in the Shareholder Agreement, UAT would grant Molina the exclusive
option (called the "PUT") to require UAT to purchase all UAHC Health Plan stock
owned by Molina for a price equal to the percentage share of UAHC Health Plan
then owned by Molina multiplied by the Total Value of UAHC Health Plan. Molina
could exercise the Put any time between the dates that are 60 and 72 months from
the effective date of the new TennCare contract. Accordingly, Molina could
exercise the Put any time between November 1, 2013 and November 1, 2014 if the
contract effective date for this purpose is November 1, 2008, or between January
1, 2014 and January 1, 2015 if the contract effective date for this
15
purpose is January 1, 2009. As used in the Shareholder Agreement, the "Total
Value of UAHC Health Plan" would be (i) the valuation proposed in writing by
Molina with its notice of exercising the Put, if agreed to by UAT, or (ii) the
alternative valuation proposed by UAT to Molina, or (iii) if Molina and UAT
could not agree upon the Total Value of UAHC Health Plan within 30 days after
Molina's notice of exercising the Put, the valuation determined by arbitration
procedures set forth in the Purchase Agreement.
The Shareholder Agreement would require a 12-member Board of Directors of
UAHC Health Plan, with Molina and UAT electing directors in proportion to their
respective ownership interests. If two full-risk TennCare contracts are awarded
to UAHC Health Plan, then certain matters specified in the Shareholder Agreement
would require the unanimous approval of the Board of Directors.
REGULATORY MATTERS
Certain federal and state regulatory requirements must be complied with
before the Transactions are consummated. The Company, UAHC Health Plan and UAT
are not aware of any material governmental consents or approvals that are
required prior to the parties' consummation of the Transactions other than those
described below. It is currently contemplated that if such additional
governmental consents or approvals are required, they will be sought. There can
be no assurance, however, that any such additional consents or approvals will be
obtained.
HART-SCOTT-RODINO ACT
The sale to Molina of a minority interest in UAHC Health Plan is not
subject to the requirements of the federal Hart-Scott-Rodino Act ("H-S-R ACT")
and the rules and regulations thereunder, which provide that certain acquisition
transactions may not be consummated until certain information has been furnished
to the Antitrust Division of the U.S. Department of Justice and the Federal
Trade Commission and until certain waiting periods have been terminated or have
expired.
However, a future sale of the remaining stock of UAHC Health Plan, pursuant
to Molina's Purchase Option, may or may not be subject to such H-S-R Act
requirements. This will depend upon whether, at the time of the exercise of
Molina's Purchase Option, (A) the size of the transaction in terms of purchase
price meets the applicable threshold established by the H-S-R Act and the rules
and regulations thereunder (currently $63,100,000) or (b) the size of the
parties to the transaction meets the thresholds established by the H-S-R Act and
the rules and regulations thereunder (currently the acquired party must have
more than $12,600,000 in total assets and the acquiring party must have more
than $126,200,000 in sales or total assets in order for the H-S-R Act's
requirements to apply). These thresholds are subject to change from time to time
by administrative action of the federal government.
It is contemplated that if H-S-R Act filings are required, upon exercise of
Molina's Purchase Option, such filings will be made and the applicable waiting
periods will be complied with by the parties prior to the consummation of any
such sale pursuant to such option.
STATE OF TENNESSEE
Certain informational filings with, and approval by, the Commissioner of
the State of Tennessee's Department of Commerce and Insurance may be required in
connection with the acquisition of shares of stock of a Tennessee health
maintenance organization. We expect that any such requirement with respect to
UAHC Health Plan stock in connection with the Transactions will be timely
observed and satisfied if and when required.
16
UNAUDITED PRO FORMA FINANCIAL INFORMATION
The Company and its consolidated subsidiaries, UAT and UAHC Health Plan,
entered into a Purchase Agreement with Molina dated as of March 24, 2008. Under
the Purchase Agreement, if (and only if) UAHC Health Plan enters into at least
one new TennCare contract pursuant to TennCare's RFP, Molina will become a part
owner of UAHC Health Plan by purchasing newly issued UAHC Health Plan stock from
UAHC Health Plan - either (1) shares representing 19.9% of the total issued and
outstanding UAHC Health Plan stock for a cash purchase price of $4,500,000 in
the event that UAHC Health Plan executes one new TennCare contract; or (2)
shares representing 49.9% of the total issued and outstanding UAHC Health Plan
stock for a cash purchase price of $18,040,000 in the event that UAHC Health
Plan executes two new TennCare contracts. The closing of that purchase of stock
by Molina is dependent upon an award of either one or two new TennCare contracts
to UAHC Health Plan. (See "PROPOSAL: THE TRANSACTIONS - Introduction" above.)
Under the Shareholder Agreement to be executed pursuant to the Purchase
Agreement, Molina will be granted an option to purchase all of the remaining
outstanding shares of UAHC Health Plan from UAT during a future period
determined as described under "SUMMARY TERM SHEET - When Molina Can Exercise Its
Option to Buy-Out Our Interest in UAHC Health Plan" above. Exactly when that
period will begin and end depends on facts that cannot yet be known.
Consequently, for the purpose of presenting pro forma financial information in
this proxy statement, we have assumed Molina will exercise its buy-out option on
November 1, 2010(2) (our assumed "OPTION EXERCISE DATE"). It is important that
you realize that this assumption is necessarily made in order to provide an
illustrative pro forma example, and that the actual Option Exercise Date could
be any of a large number of other potential dates.
In the event of the exercise of Molina's Purchase Option pursuant to the
Shareholder Agreement, Molina will purchase substantially all of the Company's
assets, except for cash, cash equivalents and marketable securities.(3) The
purchase price payable to UAT by Molina will be an amount in cash equal to the
percentage interest that UAT then owns of the outstanding UAHC Health Plan stock
multiplied by the Fair Market Value of UAHC Health Plan determined as of the
purchase closing date. For this purpose, the Fair Market Value of UAHC Health
Plan will equal the sum of (1) its Medicaid membership multiplied by $345 per
Medicaid member, plus (2) its Medicare Advantage and/or Medicare Advantage
Special Needs Plan membership multiplied by $2,500 per Medicare member, plus (3)
the market value of its Medicare Advantage Prescription Drug Program plan
business operations, if any, plus (4) the sum of capital then held by UAHC
Health Plan in excess of the statutory minimum capital required. None of these
four amounts is currently determinable.
Set forth below is the Unaudited Pro Forma Condensed Consolidated Balance
Sheet of the Company as of December 31, 2007, which has been prepared for
illustrative purposes as if Molina's purchase of all of UAT's UAHC Health Plan
stock pursuant to Molina's buy-out option was
----------
(2) Under the Purchase Agreement, November 1, 2010 is the earliest date for
Molina's exercise of its buy-out option under any possible fact situation
(other than certain potential instances of Molina's contributing required
capital to UAHC Health Plan if UAT would decline to contribute its own
proportionate share; see "Also When Molina Can Exercise Its Option to
Buy-Out Our Interest in UAHC Health Plan" in the Summary Term Sheet
on p.3). It is the earliest date that would be possible for that exercise
if UAHC Health Plan received (A) only one new TennCare contract pursuant
to the RFP, (B) for the West Grand Region, and (C) effective
November 1, 2008. Each of those facts potentially could be different, and
even on those facts, Molina could exercise the option as late as
November 1, 2010. At the opposite extreme, Molina potentially could
exercise the option as late as January 1, 2014. See "SUMMARY TERM SHEET -
When Molina Can Exercise Its Option to Buy-Out Our Interests in UAHC Health
Plan" above.
(3) See footnote 1 on page 3 of this proxy statement.
17
consummated as of that date. The consummation of Molina's stock purchase
pursuant to its exercised buy-out option is sometimes called the "BUY-OUT
CLOSING" below. Although a Pro Forma Condensed Consolidated Statement of
Operations has not been prepared, the pro forma effect on the Company's
consolidated operations for the six months ended June 30, 2007 and December 31,
2007 if the Buy-Out Closing occurred as of July 1, 2006 is described in Note 2
in the Notes to the Unaudited Pro Forma Financial Information below.
The accompanying unaudited pro forma condensed consolidated financial
statements are presented for informational purposes only and are subject to a
number of estimates, assumptions and other uncertainties; and they neither
purport to represent what the Company's consolidated results of operations or
financial position actually would have been if the Buy-Out Closing occurred on
the dates specified, nor purport to project the Company's consolidated results
of operations or financial position for any future period or at any future date.
All pro forma adjustments are necessarily based on preliminary estimates and
assumptions and are subject to revision upon Molina's actual exercise of its
buy-out option and the actual Buy-Out Closing. The pro forma financial
information and the accompanying Notes to the Unaudited Pro Forma Financial
Information contained in this proxy statement should be read in conjunction with
the financial statements and notes thereto and the Management's Discussion and
Analysis of Financial Condition and Results of Operation included in the
Company's Annual Report on Form 10-K for the year ended June 30, 2007 and in the
Company's Quarterly Report on Form 10-Q for the period ended December 31, 2007.
The objective of the unaudited pro forma financial information in this
proxy statement is to show what the significant effects on the Company's
historical consolidated financial statements might have been if Molina's
exercise of its buy-out option and the Buy-Out Closing occurred for balance
sheet purposes on December 31, 2007. The pro forma balance sheets are not
necessarily indicative of the effects on the Company's financial position that
would have been attained if such option exercise and the Buy-Out Closing had
occurred then. The pro forma adjustments are based on information currently
available and on certain assumptions, as described in the Notes to the Unaudited
Pro Forma Financial Information below, that management of the Company believes
are necessary and reasonable for a fair presentation of the pro forma financial
information.
The following two Unaudited Pro Forma Condensed Consolidated Balance Sheets
as of December 31, 2007, give the effect of the Buy-Out Closing based on the
alternative assumptions that UAHC Health Plan enters into either one or two new
TennCare contracts pursuant to the TennCare RFP.
(Balance of this page intentionally left blank)
18
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET,
ASSUMING A SINGLE TENNCARE CONTRACT
(in thousands)
AS OF DECEMBER 31, 2007
-------------------------------------
PRO FORMA
AS REPORTED ADJUSTMENTS PRO FORMA
----------- ----------- ---------
(Unaudited)
ASSETS
Current assets
Cash and cash equivalents $10,174 $51,349 $61,523
Marketable securities 6,666 (3,860) 2,806
Accounts receivable - State of TN, net 1,705 (1,705) --
Interest receivable 532 (532) --
Other receivables 235 (235) --
Prepaid expenses and other 323 (192) 131
Deferred income taxes 1,878 (1,878) --
------- ------- -------
Total current assets 21,513 42,947 64,460
Property and equipment, net 451 (438) 13
Goodwill 3,452 (3,452) --
Marketable securities 7,573 (7,573) --
Restricted assets 421 -- 421
Other assets 586 -- 586
------- ------- -------
Total assets $33,996 $31,484 $65,480
======= ======= =======
LIABILITIES AND SHAREHOLDERS' EQUITY
Medical claims payable $ 2,769 $(2,657) $ 112
Accounts payable and accrued expenses 885 (328) 557
Federal income tax payable 7,218 7,218
Accrued compensation and related benefits 626 (385) 241
Accrued rent 112 (112) --
Other current liabilities 1,015 (1,015) --
------- ------- -------
Total current liabilities 5,407 2,721 8,128
------- ------- -------
Total liabilities 5,407 2,721 8,128
Shareholders' equity
Preferred stock, 5,000,000 shares
authorized; none issued -- -- --
Common stock, no par, 15,000,000 shares
authorized; 8,690,666 issued and
outstanding at December 31, 2007 18,450 -- 18,450
Additional paid-in-capital - stock options 1,010 -- 1,010
Warrants 444 -- 444
Retained earnings 8,632 28,816 37,448
Accumulated other comprehensive income,
net of income taxes 53 (53) --
------- ------- -------
Total shareholders' equity 28,589 28,763 57,352
------- ------- -------
Total liabilities and shareholders'equity $33,996 $31,484 $65,480
======= ======= =======
See accompanying Notes to the Unaudited Pro Forma Financial Information.
19
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET,
ASSUMING TWO TENNCARE CONTRACTS
(in thousands)
AS OF DECEMBER 31, 2007
-------------------------------------
PRO FORMA
AS REPORTED ADJUSTMENTS PRO FORMA
----------- ----------- ---------
(Unaudited)
ASSETS
Current assets
Cash and cash equivalents $10,174 67,755 $77,929
Marketable securities 6,666 (3,860) 2,806
Accounts receivable - State of TN, net 1,705 (1,705) --
Interest receivable 532 (532) (0)
Other receivables 235 (235) 0
Prepaid expenses and other 323 (192) 131
Deferred income taxes 1,878 (1,878) --
------- ------ -------
Total current assets 21,513 59,353 80,866
Property and equipment, net 451 (438) 13
Goodwill 3,452 (3,452) --
Marketable securities 7,573 (7,573) --
Restricted assets 421 -- 421
Other assets 586 -- 586
------- ------ -------
Total assets $33,996 47,890 $81,886
======= ====== =======
LIABILITIES AND SHAREHOLDERS' EQUITY
Medical claims payable 2,769 (2,657) 112
Accounts payable and accrued expenses 885 (328) 557
Federal income tax payable 13,305 13,305
Accrued compensation and related benefits 626 (385) 241
Accrued rent 112 (112) --
Other current liabilities 1,015 (1,015) --
------- ------ -------
Total current liabilities 5,407 8,808 14,215
------- ------ -------
Total liabilities 5,407 8,808 14,215
Shareholders' equity
Preferred stock, 5,000,000 shares
authorized; none issued
Common stock, no par, 15,000,000 shares
authorized; 8,690,666 issued and
outstanding at December 31, 2007 18,450 -- 18,450
Paid-in-capital - stock options 1,010 -- 1,010
Warrants 444 -- 444
Retained earnings 8,632 39,135 47,767
Accumulated other comprehensive income, net
of income taxes 53 (53) --
------- ------ -------
Total shareholders' equity 28,589 39,082 67,671
------- ------ -------
Total liabilities and shareholders'equity $33,996 47,890 $81,886
======= ====== =======
See accompanying Notes to the Unaudited Pro Forma Financial Information.
20
NOTES TO THE UNAUDITED PRO FORMA FINANCIAL INFORMATION
NOTE 1 - PRO FORMA BALANCE SHEETS
Reflected in the Pro Forma Balance Sheets is the following:
Cash and cash equivalents - Includes the cash from the exercise of the Molina
option to purchase all of UAT's shares of UAHC Health Plan stock. The purchase
price payable to UAT by Molina will be an amount in cash equal to the percentage
interest that UAT then owns of the outstanding UAHC Health Plan stock multiplied
by the Fair Market Value of UAHC Health Plan determined as of the purchase
closing date. For this purpose, the Fair Market Value of UAHC Health Plan will
equal the sum of (1) its Medicaid membership (assumed to be approximately
181,000 members if there is one TennCare contract and 388,000 members if there
are two TennCare contracts) multiplied by $345 per Medicaid member, plus (2) its
Medicare Advantage and/or Medicare Advantage Special Needs Plan membership
(assumed to be 815 members) multiplied by $2,500 per Medicare member, plus (3)
the market value of its Medicare Advantage Prescription Drug Program plan
business operations, if any (assumed to be zero since there currently are none),
plus (4) the sum of capital then held by UAHC Health Plan in excess of its
statutory minimum net worth requirement. Since it is not possible to reasonably
determine the amount of capital in excess of the minimum net worth requirement
at the assumed Option Exercise Date (November 1, 2010), which will be impacted
by the net earnings or net loss performance of UAHC Health Plan from the assumed
effective date of a new TennCare contract (November 1, 2008) through the assumed
Option Exercise Date (November 1, 2010), we assume the excess capital at the at
the Buy-Out Closing date is equal to the excess capital at the assumed contract
effective date (November 1, 2008). Thus, the estimated cash purchase price is
$58.6 million in the event of one new TennCare contract or $75.7 million in the
event of two new TennCare contracts.
Deferred income taxes - The deferred tax assets as reported at December 31, 2007
are utilized to offset the gain on the sale of the UAHC Health Plan subsidiary
in the pro forma financial statements.
Property and equipment, net - Molina would purchase substantially all of the
physical assets of UAT that relate to UAHC Health Plan. The purchase price
payable to UAT by Molina as described two paragraphs above will be for the
purchase of those assets as well as for the purchase of all of UAT's shares of
UAHC Health Plan stock.
Federal income tax payable - An adjustment is recorded for the estimated tax
liability of $7.2 million in the event of one new TennCare contract, or $13.3
million in the event of two new TennCare contracts, associated with the gain on
the sale of the UAHC Health Plan subsidiary.
NOTE 2 - INCOME STATEMENT
For the purposes of this pro forma analysis, we assume that the exercise by
Molina of its option to purchase all of UAT's shares of UAHC Health Plan stock
will involve the sale of substantially all of the Company's non-cash assets to
Molina; that following the closing of such transaction the Company will
effectively be a corporation with only cash, cash equivalents and marketable
securities and no intangible assets or ongoing business operations; and that the
Company will incur only costs and expenses associated with remaining a publicly
held company and efforts to complete an acquisition or enter into a strategic
transaction or alliance with a potential business partner. These costs and
estimates are difficult to estimate at this time as they are dependent on many
factors, including the availability of potential
21
acquisition targets or potential strategic business partners and the time
and effort required to negotiate and complete such transactions.
The unaudited pro forma narrative income statement for the fiscal year ended
June 30, 2007, assuming that the Buy-Out Closing date was July 1, 2006, would
reflect all of the revenue and expenses associated with the Company's only
business operation being eliminated. The only remaining costs of approximately
$3.5 million on a pro forma basis relate to maintaining an ongoing publicly held
company, and costs expended to identify potential acquisition targets or
business partner candidates. The $3.5 million includes salaries of existing
management and professional consulting and financial advisor expense of $0.3
million expected to assist in the completion of a transaction with an
acquisition target or a strategic business partner. The costs associated with
identifying potential acquisition targets or business partner candidates will
continue until such time as an agreement with such a partner is completed or the
Company decides to abandon such efforts. These costs will be offset by net other
income of approximately $3.6 million if there is one TennCare contract or $4.6
million if there are two TennCare contracts, after giving effect to interest
income from the investment of the consideration received from the Buy-Out
Closing, resulting in net earnings on a pro forma basis of approximately $0.1
million or $0.02 per basic and diluted share if there is one TennCare contract,
or $0.7 million or $0.08 per basic share and $0.07 per diluted share if there
are two TennCare contracts, based on 8,734,214 basic and 9,694,360 fully diluted
shares outstanding, respectively.
For the purposes this pro forma analysis, we assume that the Company will also
incur legal expenses for ongoing litigation for which the ultimate liability
cannot be quantified or estimated with any reasonable certainty.
The Company will incur approximately $0.1 million for legal services provided by
the Company's outside counsel and $0.4 million if there is one TennCare
contract, or $1.0 million if there are two TennCare contracts, for ongoing
consulting services provided to the Company in connection with the completion of
the transactions contemplated by the Purchase Agreement.
ACCOUNTING TREATMENT
In the event of the exercise of Molina's Purchase Option pursuant to the
Shareholder Agreement, Molina will purchase 100% of UAT's remaining interest in
UAHC Health Plan and substantially all of UAT's assets, except for cash, cash
equivalents and marketable securities(4). UAT would record the disposition of
these assets and its remaining interest in UAHC Health Plan and a corresponding
gain or loss representing the difference between the proceeds received by UAT
and UAT's carrying value of the assets given up, net of applicable state and
federal income taxes. See "UNAUDITED PRO FORMA FINANCIAL INFORMATION" for
additional information.
FEDERAL INCOME TAX CONSEQUENCES
In the event of the exercise of Molina's Purchase Option pursuant to the
Shareholder Agreement, any gain realized from the sale of UAT's interest in UAHC
Health Plan and other assets sold will be taxable at the applicable state and
federal tax rates. The amount of the gain or loss recognized by the Company with
respect to the sale of UAT's remaining interest in UAHC Health Plan and other
assets sold will be measured by the difference between the proceeds received and
the tax basis in the assets and interest sold. UAT files a consolidated tax
return with its parent, the Company, as a consolidated group.
The proposed sale of substantially all of the non-cash assets of the
Company by itself will not produce any separate and independent federal income
tax consequences to the Company's shareholders.
----------
(4) See footnote 1 on page 3 of this proxy statement.
22
EXPENSES OF SOLICITATION
The cost of this solicitation of proxies will be borne by the Company and
may include requests by mail and personal contact by its Directors, officers and
employees. In addition, the Company has retained Georgeson Shareholder to aid in
the solicitation of proxies from brokers, banks, other nominees and
institutional holders at a fee not to exceed $8,500 plus out-of-pocket expenses.
The Company will reimburse brokers or other nominees and institutional holders
for their expenses in forwarding proxy materials to principals. Any person
giving a proxy has the power to revoke it at any time before it is voted.
SHAREHOLDER PROPOSALS
Proposals of shareholders that are intended to be presented at our 2008
Annual Meeting of Shareholders must be received by our Secretary at our
offices, United American Healthcare Corporation, 300 River Place, Suite 4950,
Detroit, Michigan 48207-5062, no later than May 26, 2008 to be considered for
inclusion in the proxy statement and form of proxy relating to that meeting.
Such proposals should be sent by certified mail, return receipt requested.
We must receive notice of any proposals of shareholders that are intended
to be presented at our 2008 Annual Meeting of Shareholders, but that are not
intended to be considered for inclusion in our proxy statement and proxy related
to that meeting, no later than August 6, 2008 to be considered timely. Such
proposals should be sent by certified mail, return receipt requested and
addressed to United American Healthcare Corporation, 300 River Place, Suite
4950, Detroit, Michigan 48207-5062, Attention: Investor Relations Department. If
we do not have notice of the matter by that date, our form of proxy in
connection with that meeting may confer discretionary authority to vote on that
matter, and the persons named in our form of proxy will vote the shares
represented by such proxies in accordance with their best judgment.
OTHER BUSINESS
Neither we nor the members of our Board of Directors intend to bring before
the Special Meeting any matters other than those set forth in the Notice of the
Special Meeting of Shareholders, and none of us has any present knowledge that
other matters will be presented for action at the Special Meeting by others.
However, if other matters are properly presented to the meeting, the persons
named in the enclosed proxy intend to vote the shares represented by the proxy
in accordance with their best judgment.
By order of the Board of Directors
/s/ William C. Brooks
William C. Brooks
Chairman, President and Chief
Executive Officer
Detroit, Michigan
________, 2008
DETROIT.3051021.2
23
APPENDIX A
PURCHASE AGREEMENT
UAHC HEALTH PLAN OF TENNESSEE, INC.
TABLE OF CONTENTS
Page
----
Exhibit A Definitions
Exhibit B Notices
Exhibit C Affiliate Agreements
Exhibit D Shareholder Agreement
ARTICLE I PURCHASE AND SALE OF SHARES ................................... 1
1.1 Shares .......................................................... 1
1.2 Purchase Price .................................................. 2
1.3 Closing ......................................................... 2
1.4 Transfer of Shares .............................................. 2
1.5 Deliveries by Buyer at Closing .................................. 2
1.6 Deliveries by the Company at Closing ............................ 3
1.7 Deliveries by Owner at Closing .................................. 3
ARTICLE II REPRESENTATIONS AND WARRANTIES ............................... 4
2.1 General Statement ............................................... 4
2.2 Representations and Warranties of Buyer ......................... 4
2.3 Representations and Warranties of Owner ......................... 6
2.4 Representations and Warranties of the Company and the Owner
Regarding the Company ........................................... 7
2.5 Survival of Representations and Warranties ...................... 16
ARTICLE III CONDUCT PRIOR TO CLOSING .................................... 17
3.1 Obligations of the Company ...................................... 17
3.2 Obligations of Owner ............................................ 19
3.3 Joint Obligations ............................................... 19
3.4 Amended Governing Documents ..................................... 20
ARTICLE IV CONDITIONS TO CLOSING ........................................ 20
4.1 Conditions to Buyer's Obligations ............................... 20
4.2 Conditions to Owner's Obligations ............................... 21
4.3 Conditions to the Company's Obligations ......................... 21
ARTICLE V POST-CLOSING COVENANTS ........................................ 22
5.1 Execution of Documents .......................................... 22
5.2 Books and Records ............................................... 22
i
ARTICLE VI INDEMNIFICATION .............................................. 22
6.1 Indemnification by Owner ........................................ 22
6.2 Indemnification by Buyer ........................................ 23
6.3 Notice of Claim for Indemnification ............................. 23
6.4 Defense of Undisputed Claims .................................... 23
6.5 Disputed Claims for Indemnification ............................. 24
6.6 Payment by the Company .......................................... 24
6.7 Exclusive Remedy ................................................ 24
ARTICLE VII TERMINATION ................................................. 24
7.1 Termination of Agreement ........................................ 24
7.2 Effect of Termination ........................................... 25
ARTICLE VIII MISCELLANEOUS .............................................. 25
8.1 Construction .................................................... 25
8.2 Press Releases and Public Announcements ......................... 25
8.3 Entire Agreement ................................................ 26
8.4 No Third-Party Beneficiaries .................................... 26
8.5 Further Assurances .............................................. 26
8.6 Successors and Assigns .......................................... 26
8.7 Assignment ...................................................... 26
8.8 Amendment ....................................................... 26
8.9 Notices ......................................................... 26
8.10 Expenses and Attorneys' Fees .................................... 27
8.11 Waivers ......................................................... 27
8.12 Severability .................................................... 27
8.13 Binding Arbitration ............................................. 27
8.14 Recitals ........................................................ 29
8.15 Exhibits and Disclosure Schedule ................................ 29
8.16 Disclosure ...................................................... 29
8.17 Counterparts .................................................... 29
ii
LIST OF SCHEDULES
Section 2.4.7 Officers and Managers
Section 2.4.10 Title to Assets
Section 2.4.11(a) Financial Statements
Section 2.4.11(b) Unaudited Financial Statements
Section 2.4.11(c) Reserves
Section 2.4.15(b) Leases of real property
Section 2.4.16(a) Intellectual Property
Section 2.4.16(b) Liens
Section 2.4.16(a) Claims; Infringements; Copyright registration, Patent and
Registered Trademark and application
Section 2.4.17(a) Undischarged Contracts
Section 2.4.17(d) Designated Contract
Section 2.4.18 Litigation
Section 2.4.19 [Intentionally Left Blank]
Section 2.4.24(c) Employee matters; respective base salaries and positions
Section 2.4.26 Suppliers
Section 2.4.27 Insurance
Section 2.4.30 Bank Accounts
Section 2.4.31(a) Provider Agreements
Section 2.4.31(c) Negotiations regarding Provider Agreements
Section 2.4.32 Payments under Medicaid Contract
Section 2.4.33 Payments under Medicare Contract
Section 3.1 Conduct of Business
iii
PURCHASE AGREEMENT
THIS PURCHASE AGREEMENT ("Agreement") is entered into as of March 24, 2008
("Agreement Date"), by and among Molina Healthcare, Inc., a Delaware corporation
("Buyer"), UAHC Health Plan of Tennessee, Inc., a Tennessee corporation ("The
Company"), United American of Tennessee, Inc. ("UAT") and United American
Healthcare Corporation, a Michigan corporation ("UAHC") (collectively, UAT and
UAHC are referred to herein as "Owner"). Each of Buyer, the Company, and Owner
is referred to herein as a "Party" and collectively as the "Parties."
DEFINITIONS
Unless otherwise defined in the text of this Agreement, capitalized names
and terms herein and in the Exhibits and the Disclosure Schedule shall have the
meaning ascribed to them in Exhibit A.
RECITALS
A. The Company holds a certificate of authority from the DOI to operate a
health maintenance organization and at Closing will arrange for the provision of
comprehensive health care services pursuant to, and in accordance with, the
Medicaid Contract and the Medicare Contract.
B. UAT owns one hundred percent (100%) of the issued and outstanding stock
of the Company, and UAHC owns one hundred percent (100%) of the issued and
outstanding stock of UAT.
C. Owner desires Company to issue the Shares to Buyer, and Buyer desires to
purchase the Shares from Company, pursuant to the provisions of this Agreement.
AGREEMENTS
NOW, THEREFORE, in consideration of the premises and the mutual promises
herein made, and in consideration of the representations, warranties and
covenants herein contained, the Parties agree as follows:
ARTICLE I
PURCHASE AND SALE OF SHARES
1.1 SHARES. Subject to the provisions of this Agreement, Buyer shall
acquire from Company, and Company shall issue to Buyer, the Shares free and
clear of any restrictions on transfer or Liens for the consideration specified
in Section 1.2.
1
1.2 PURCHASE PRICE. Subject to Section 1.9.2, Buyer shall pay the Purchase
Price to Company at the Closing by wire transfer of immediately available
Federal funds to an account or accounts designated by Company prior to the
Closing.
1.3 CLOSING. The Closing shall take place at the offices of the Company,
commencing at 9:00 a.m. local time on (a) such date as may be agreed upon by
Buyer and Owner in writing that is no earlier than the date the State Agency
executes the Full-Risk Medicaid contract with Company, and is no later than the
effective date of such Full-Risk Medicaid contract (the go-live date), or (b)
such other date as Buyer and Owner may mutually agree in writing.
1.4 TRANSFER OF SHARES. At the Closing, Company shall sell, issue, convey
and deliver the Shares to Buyer free and clear of any restrictions on transfer
or Liens.
1.5 DELIVERIES BY BUYER AT CLOSING. At the Closing, Buyer shall deliver to
Company:
1.5.1 The Purchase Price;
1.5.2 A copy of resolutions duly adopted by the Board of Buyer and
signed by the Secretary thereof authorizing the execution, delivery and
performance by Buyer of this Agreement and all related agreements, documents and
instruments;
1.5.3 A certificate of the Secretary of Buyer certifying (a) the
incumbency of the officers of Buyer on the Agreement Date and on the Closing
Date and bearing the authentic signatures of all such officers who shall execute
this Agreement and any additional documents contemplated by this Agreement, and
(b) that the resolutions identified in Section 1.5.2 remain in full force and
effect on the Closing Date;
1.5.4 A certificate of the Chairman of the Board of Buyer certifying
that (a) the representations of Buyer set forth in Section 3.2 are true and
correct as of the Closing Date, (b) Buyer has performed and complied in all
material respects with its covenants in this Agreement through the Closing, and
(c) all of the conditions precedent to the obligations of Buyer under Article V
have been satisfied or waived;
1.5.5 An original certificate of corporate good standing of Buyer,
issued by the Secretary of State of Delaware and dated no earlier than 30 days
prior to the Closing Date;
1.5.6 A counterpart of the Affiliate Agreements executed by the
appropriate parties;
1.5.7 A counterpart of the Shareholder Agreement executed by Buyer;
and
1.5.8 Such other instruments, certificates and other documents as are
(a) reasonably necessary for Buyer to implement, as of the Closing Date, the
transactions contemplated by this Agreement and to comply with the terms hereof,
and (b) required pursuant to the terms of this Agreement.
2
1.6 DELIVERIES BY THE COMPANY AT CLOSING. At the Closing, the Company shall
deliver to Buyer:
1.6.1 Properly issued stock certificates evidencing the issuance of
the Shares to Buyer;
1.6.2 Releases of any Liens on the Shares or the assets of the
Company;
1.6.3 A copy of resolutions duly adopted by the Board of the Company
and signed by the Secretary thereof (a) authorizing the execution, delivery and
performance by the Company of this Agreement and all related agreements,
documents and instruments, (b) approving the issuance of the Shares by the
Company to Buyer, and (c) authorizing the filing of any Amended Articles
effective as of the Closing.
1.6.4 A certificate of the Secretary of the Company certifying (a) the
incumbency of the officers of the Company on the Agreement Date and on the
Closing Date and bearing the authentic signatures of all such officers who shall
execute this Agreement and any additional documents contemplated by this
Agreement, and (b) that the resolutions identified in Section 1.6.3 remain in
full force and effect on the Closing Date;
1.6.5 A certificate of the Chairman of the Board of the Company
certifying that the Company has performed and complied in all material respects
with its covenants in this Agreement through the Closing;
1.6.6 An original certificate of corporate good standing of the
Company, issued by the Tennessee Secretary of State and dated no earlier than 30
days prior to the Closing Date;
1.6.7 A counterpart of the Affiliate Agreements executed by the
appropriate parties;
1.6.8 A counterpart of the Shareholder Agreement executed by the
Company; and
1.6.9 Such other instruments, certificates and other documents as are
(a) reasonably necessary for the Company to implement, as of the Closing Date,
the transactions contemplated by this Agreement and to comply with the terms
hereof, and (b) required pursuant to the terms of this Agreement.
1.7 DELIVERIES BY OWNER AT CLOSING. At the Closing, Owner shall deliver to
Buyer:
1.7.1 An original executed certificate by Owner stating that (a) the
representations of Owner set forth in Section 3.3 and Section 3.4 are true and
correct as of the Closing Date, (b) Owner has performed and complied in all
material respects with the covenants of Owner in this Agreement, and (c) all of
the conditions precedent to the obligations of Owners under this Agreement have
been satisfied or waived;
1.7.2 A copy of resolutions duly adopted by the Board of Owner and
signed by the Secretary thereof (a) authorizing the execution, delivery and
performance by Owner of this
3
Agreement and all related agreements, documents and instruments, and (b)
approving the issuance of the Shares by the Company to Buyer;
1.7.3 A certificate of the Secretary of Owner certifying (a) the
incumbency of the officers of Owner on the Agreement Date and on the Closing
Date and bearing the authentic signatures of all such officers who shall execute
this Agreement and any additional documents contemplated by this Agreement, and
(b) that the resolutions identified in Section 1.7.2 remain in full force and
effect on the Closing Date;
1.7.4 A certificate of the Chairman of the Board of Owner certifying
that Owner has performed and complied in all material respects with its
covenants in this Agreement through the Closing;
1.7.5 An original certificate of good standing of Owner, issued by the
Secretary of State of Michigan and dated no earlier than 30 days prior to the
Closing Date;
1.7.6 A counterpart of the Affiliate Agreements executed by the
appropriate parties;
1.7.7 A counterpart of the Shareholder Agreement executed by Owner;
and
1.7.8 Such other instruments, certificates and other documents as are
(a) reasonably necessary for Owner or the Company to implement, as of the
Closing Date, the transactions contemplated by this Agreement and to comply with
the terms hereof, and (b) required pursuant to the terms of this Agreement.
ARTICLE II
REPRESENTATIONS AND WARRANTIES
2.1 GENERAL STATEMENT. Subject to Section 2.5, all representations and
warranties set forth in this Article III and in any Financial Statement,
Exhibit, the Disclosure Schedule, certificate or other document attached hereto
or delivered by a Party in connection herewith shall survive the consummation of
the transactions contemplated by this Agreement. No specific representation or
warranty shall limit the generality or applicability of a more general
representation or warranty.
2.2 REPRESENTATIONS AND WARRANTIES OF BUYER. Buyer hereby represents to
Owner that the following facts and circumstances are true and correct and Buyer
acknowledges that such facts and circumstances constitute a material inducement
for the execution of this Agreement by Owner:
2.2.1 Organization and Good Standing. Buyer is a corporation, duly
incorporated, validly existing and in good standing under the laws of the State
of Delaware.
2.2.2 Authority and Enforceability. Buyer has full power and
authority, including full corporate power and authority, to execute, deliver and
perform its respective obligations under this Agreement. The execution, delivery
and performance of this Agreement and all other agreements contemplated by this
Agreement have been duly authorized by Buyer.
4
Assuming the due authorization, execution and delivery by each other Party, this
Agreement constitutes a valid and legally binding obligation of Buyer,
enforceable in accordance with its terms and conditions.
2.2.3 Consents. Buyer is not required to give any notice to, make any
filing with or obtain any authorization, consent or approval of any Governmental
Entity in order to consummate the transactions contemplated by this Agreement
other than as may be required of Buyer (a) under the HSR Act, (b) to obtain any
required approvals of the DOI, (c) to obtain any required consent from, or make
any disclosure to, the State Agency, and (d) obtain any required consent from,
or make any disclosure to, CMS.
2.2.4 Non-Contravention. Neither the execution and the delivery of
this Agreement nor the consummation of the transactions contemplated by this
Agreement will (a) violate any constitution, statute, regulation, rule,
injunction, judgment, order, decree, ruling, charge or other restriction of any
Governmental Entity to which Buyer is subject or any provision of its charter,
bylaws or other governing documents, or (b) conflict with, result in a breach
of, constitute a default under, result in the acceleration of, create in any
Person the right to accelerate (whether after the giving of notice or lapse of
time or both), terminate, modify or cancel, or require any notice under any
Contract, lease or License to which Buyer is a party, by which it is bound or to
which any of its assets is subject other than those breaches, defaults,
violations or conflicts which have not had, and would not reasonably be likely
to have, individually or in the aggregate, a Material Adverse Effect on Buyer.
2.2.5 Sufficient Expertise. Buyer has sufficient expertise, including
in business and financial matters, to (a) evaluate the risks related to Buyer's
decision to assume its obligations under this Agreement and the transactions
contemplated hereby, and (b) make an informed investment decision with respect
to such acquisition.
2.2.6 Investment. Buyer is acquiring the Shares pursuant to this
Agreement for Buyer's own account for investment only and not with a view to, or
for sale in connection with, any distribution of any of the Shares in violation
of the Securities Act. Buyer has no present intention of distributing or selling
the acquired Shares, and Buyer has no present or contemplated agreement,
undertaking, arrangement, obligation, indebtedness or commitment providing for
the disposition of the acquired Shares. Buyer is an "accredited investor" within
the meaning of Rule 501(a) under the Securities Act. Buyer understands that (a)
the Shares have not been registered under the Securities Act and are "restricted
securities" within the meaning of Rule 144 under the Securities Act, and (b) the
Shares cannot be sold, transferred or otherwise disposed of unless they are
subsequently registered under the Securities Act or an exemption from
registration is then available.
2.2.7 Pending Proceedings. There are no actions, suits, arbitrations,
mediations or other legal proceedings by any Third Party, and there are no
administrative proceedings or governmental investigations, in each instance
which are pending or, to the Knowledge of Buyer, threatened against or affecting
Buyer which, if determined adversely to Buyer, reasonably could be expected to
impact Buyer's ability to consummate the transactions contemplated by this
Agreement.
5
2.2.8 Brokers. Neither Buyer nor any Person acting on Buyer's behalf
has retained or dealt with any Person who is entitled, directly or indirectly,
to a broker's commission, finder's fee, investment banker's fee or similar
payment from Owner or the Company.
2.2.9 Due Diligence. With respect to its evaluation of the merits and
risks of its decision to assume its obligations under this Agreement and the
transactions contemplated hereby, Buyer has (a) had an adequate opportunity to
conduct due diligence and to obtain such information about the Company as Buyer
deems necessary, (b) conducted due diligence to the extent deemed necessary by
Buyer, and (c) received adequate information about the Company.
2.2.10 Update of Information. Each of the representations made by
Buyer in this Section 2.2 shall be deemed made and given on the Agreement Date
and continuously thereafter until the Closing. During the period from the
Agreement Date until the Closing, Buyer promptly shall give Owner written notice
at such times as Buyer determines that any representation made in this Section
2.2 would cease to be correct if such representation were made on such date,
contains any untrue statement of a material fact or omits to state a material
fact necessary to make such representation not misleading. To be effective, each
such notice shall (a) identify, by section reference, the representation as to
which the notice relates, and (b) correctly restate the representation.
2.3 REPRESENTATIONS AND WARRANTIES OF OWNER. UAHC and UAT hereby represent
to Buyer that the following facts and circumstances are true and correct and
UAHC and UAT acknowledge that such facts and circumstances constitute a material
inducement for the execution of this Agreement by Buyer:
2.3.1 Organization and Good Standing. UAHC is a corporation, duly
incorporated, validly existing and in good standing under the laws of the State
of Michigan. UAT is a corporation, duly incorporated, validly existing and in
good standing under the laws of the State of Tennessee.
2.3.2 Authority and Enforceability. Owner has full power and
authority, including full corporate power and authority, to execute, deliver and
perform its respective obligations under this Agreement. The execution, delivery
and performance of this Agreement and all other agreements contemplated by this
Agreement have been duly authorized by Owner. Assuming the due authorization,
execution and delivery by each other Party, this Agreement constitutes a valid
and legally binding obligation of Owner, enforceable in accordance with its
terms and conditions.
2.3.3 Consents. Owner is not required to give any notice to, make any
filing with or obtain any authorization, consent or approval of any Governmental
Entity in order to consummate the transactions contemplated by this Agreement
other than as may be required of Owner (a) under the HSR Act, (b) to obtain the
required approvals of the DOI, (c) to obtain any required consent from, or make
any disclosure to, the State Agency, and (d) obtain any required consent from,
or make any disclosure to, CMS.
2.3.4 Non-Contravention. Neither the execution and the delivery of
this Agreement nor the consummation of the transactions contemplated by this
Agreement will (a)
6
violate any constitution, statute, regulation, rule, injunction, judgment,
order, decree, ruling, charge or other restriction of any Governmental Entity to
which Owner is subject or any provision of its charter, bylaws or other
governing documents, or (b) conflict with, result in a breach of, constitute a
default under, result in the acceleration of, create in any Person the right to
accelerate (whether after the giving of notice or lapse of time or both),
terminate, modify or cancel, or require any notice under any Contract, lease or
License to which Owner is a party, by which it is bound or to which any of its
assets is subject other than those breaches, defaults, violations or conflicts
which have not had, and would not reasonably be likely to have, individually or
in the aggregate, a Material Adverse Effect on Owner.
2.3.5 Brokers. Neither Owner nor any Person acting on Owner's behalf
has retained or dealt with any Person who is entitled, directly or indirectly,
to a broker's commission, finder's fee, investment banker's fee or similar
payment from Buyer, or the Company.
2.3.6 Pending Proceedings. There are no actions, suits, arbitrations,
mediations or other legal proceedings by any Third Party, and there are no
administrative proceedings or governmental investigations, in each instance
which are pending or, to the Knowledge of Owner, threatened against or affecting
Owner which, if determined adversely to Owner, reasonably could be expected to
impact Owner's ability to consummate the transactions contemplated by this
Agreement.
2.3.7 Update of Information. Each of the representations made by Owner
in this Section 2.3 shall be deemed made and given on the Agreement Date and
continuously thereafter until the Closing. During the period from the Agreement
Date until the Closing, Owner shall give Buyer written notice within a
reasonable time after Owner determines that any representation made in this
Section 2.3 would cease to be correct if such representation were made on such
date.
2.4 REPRESENTATIONS AND WARRANTIES OF THE COMPANY AND THE OWNER REGARDING
THE COMPANY. UAHC and the Company hereby represent to Buyer that the following
facts and circumstances regarding the Company are true and correct and Owner and
the Company acknowledge that such facts and circumstances constitute a material
inducement for the execution of this Agreement by Buyer:
2.4.1 Organization and Good Standing. The Company is a corporation
duly organized, validly existing and in good standing under the laws of the
State of Tennessee.
2.4.2 Authority and Enforceability. The Company has full power and
authority, including full corporate power and authority, to execute, deliver and
perform its respective obligations under this Agreement. The Company has
obtained all necessary authorizations to execute, deliver and perform this
Agreement and all other agreements contemplated by this Agreement. Assuming the
due authorization, execution and delivery by each other Party, this Agreement
constitutes a valid and legally binding obligation of the Company, enforceable
in accordance with its terms and conditions.
2.4.3 Consents. The Company is not required to give any notice to,
make any filing with or obtain any authorization, consent or approval of any
Governmental Entity in order
7
to consummate the transactions contemplated by this Agreement other than (a) as
may be required under the HSR Act, (b) to obtain the required approvals of the
DOI, (c) to obtain any required consent from, or make any disclosure to, the
State Agency, and (d) obtain any required consent from, or make any disclosure
to, CMS.
2.4.4 Non-Contravention. Neither the execution and the delivery of
this Agreement nor the consummation of the transactions contemplated by this
Agreement will (a) violate any constitution, statute, regulation, rule,
injunction, judgment, order, decree, ruling, charge or other restriction of any
Governmental Entity to which the Company is subject or any provision of its
charter, bylaws or other governing documents, or (b) conflict with, result in a
breach of, constitute a default under, result in the acceleration of, create in
any Person the right to accelerate (whether after the giving of notice or lapse
of time or both), terminate, modify or cancel, or require any notice under any
Contract, Lease or License to which the Company is a party, by which it is bound
or to which any of its assets is subject other than those breaches, defaults,
violations or conflicts which have not had, and would not reasonably be likely
to have, individually or in the aggregate, a Material Adverse Effect on the
Company.
2.4.5 Brokers. Neither the Company nor any Person acting on the
Company's behalf has retained or dealt with any Person who is entitled, directly
or indirectly, to a broker's commission, finder's fee, investment banker's fee
or similar payment from Buyer or Owner.
2.4.6 Pending Proceedings. There are no actions, suits, arbitrations,
mediations or other legal proceedings by any Third Party, and there are no
administrative proceedings or governmental investigations, in each instance
which are pending or, to the Knowledge of Owner, threatened against or affecting
the Company which, if determined adversely to the Company, reasonably could be
expected to impact the Company's ability to consummate the transactions
contemplated by this Agreement.
2.4.7 Officers and Managers. The name of each officer and manager of
the Company on the Agreement Date and his or her position with the Company are
set forth in Section 2.4.7 of the Disclosure Schedule.
2.4.8 The Company Documents. True and complete copies of the Company
Articles, bylaws, and other corporate governance documents, agreements or
instruments, each as in effect on the Agreement Date, and organizational minute
books and records of the Company, have been made available for inspection by
Buyer.
2.4.9 Ownership of the Company and Related Matters.
(a) The books and records of the Company correctly reflect that
prior to the Closing, Owner owns one hundred percent (100%) of the issued and
outstanding stock of the Company, and at the Closing, the Shares will either
represent (i) nineteen and nine-tenths percent (19.9%) of the issued and
outstanding stock of the Company in the event the Company executes one (1)
Full-Risk Medicaid Contract, or (ii) forty-nine and nine-tenths percent (49.9%)
of the issued and outstanding stock of the Company in the event the Company
executes two (2) Full-Risk Medicaid Contracts.
8
(b) Each of the Shares has been duly authorized, are validly
issued, fully paid and non-assessable.
(c) There are no outstanding or authorized options, warrants,
purchase rights, subscription rights, conversion rights, exchange rights or
other Contracts or commitments which could require the Company to issue, sell or
otherwise cause to become outstanding any of the Company's ownership interests
or any other ownership or equity interest of the Company. The Company has
neither outstanding nor authorized any stock appreciation, phantom stock, profit
participation or similar right.
(d) The Company is not a party to any Contract or commitment
which could require the Company to issue any ownership interests in the Company.
2.4.10 Title to Assets. Except as set forth in Section 2.4.10 of the
Disclosure Schedule, the Company has good and marketable title to, or a valid
leasehold interest in, the tangible assets used in the conduct of the Business,
free and clear of all Liens other than Permitted Liens.
2.4.11 Financial Reports.
(a) Complete and accurate copies of the Financial Statements are
set forth at Section 2.4.11(a) of the Disclosure Schedule. The audited Financial
Statements for 2005, 2006, and 2007 have been prepared in accordance with SAP,
accurately reflect the books and records of the Business and present fairly in
all material respects the financial condition of the Company as of their
respective dates.
(b) The unaudited Financial Statements for the period from July
1, 2007 through December 31, 2007, are set forth at Section 2.4.11(b) of the
Disclosure Schedule and have been prepared in accordance with SAP (except that
footnotes have been omitted and such statements are subject to normal, recurring
adjustments), accurately reflects the books and records of the Business and
presents fairly in all material respects the financial condition of the Company
as of the date thereof.
(c) The reserves reflected in the audited Financial Statements
for the year ended June 30, 2007, and the unaudited Financial Statements for the
period ended December 31, 2007, for unpaid medical benefits, losses, claims and
expenses incurred in connection with all lines of business of the Company were
computed by the Company and reviewed by independent licensed actuaries serving
the Company during the periods covered. There have been no changes in the
methodology used in determining reserves for such unpaid medical costs during
the prior three (3) fiscal years except as set forth in Section 2.4.11(c) of the
Disclosure Schedule.
2.4.12 Legal Compliance. The Business is in compliance in all material
respects with all Laws and the Company has not received any outstanding notice
from any Governmental Entity that alleges any violations of Laws by the Company.
Further, the Company is in compliance in all material respects with HIPAA,
including, but not limited to, obtaining business associate agreements with all
applicable business associates, and maintaining a record of all disclosures
required to be delivered to any requesting member.
9
2.4.13 Licenses. The Company holds all Licenses, including a
certificate issued by the DOI to operate as a health maintenance organization in
the State, that are necessary for the lawful conduct of the Business. Each such
License is valid, in good standing and in full force and effect and the Company
has duly performed in all material respects all of its obligations under such
Licenses.
2.4.14 Tax Matters.
(a) All Tax Returns of the Company have been duly filed and all
Taxes of the Company have been duly paid or an adequate reserve for such payment
has been established therefore in the Financial Statements.
(b) All Tax Returns of the Company are true, correct and complete
in all material respects, and there is no position taken on any such Tax Return
for which there is not substantial authority within the meaning of Section 6662
of the Code.
(c) All of the Company's Taxes which accrue or are payable by the
Company (i) in respect of taxable periods which end on or before the Closing
Date, and (ii) for any taxable period which begins before the Closing Date and
ends thereafter, to the extent such Taxes are attributable to the portion of
such period ending on the Closing Date, have or will have been timely paid on or
before the Closing Date or an adequate reserve for such payment has been
established therefore in the Financial Statements.
(d) Any unpaid Taxes of the Company did not, as of the date of
the relevant Financial Statement, exceed the accrual for such Tax liability set
forth on the relevant Financial Statement.
(e) The Company is a member of an affiliated group filing a
consolidated federal income Tax Return pursuant to the Tax Allocation Agreement.
Except pursuant to a tax sharing agreement to which the Company is a party, the
Company has no liability for Taxes of any "Person" as defined in Section
7701(a)(1) of the Code or under Treas. Reg. Section 1.1502-6 (or any similar
provision of state or local law), as a transferee or successor, by Contract or
otherwise.
(f) The Company is classified as an association taxable as a
corporation for all income Tax purposes.
(g) The Company will not be required to include any item of
income in, or exclude any item of deduction from, taxable income for any taxable
period (or portion thereof) ending after the Closing Date as a result of any (i)
change in method of accounting for a taxable period ending on or prior to the
Closing Date under Section 481(c) of the Code (or any corresponding or similar
provision of state or local income Tax law), (ii) "closing agreement" as
described in Section 7121 of the Code (or any corresponding or similar provision
of state or local income Tax law) entered into on or prior to the Closing Date,
or (iii) installment sale made on or prior to the Closing Date.
2.4.15 Real Property.
10
(a) The Company does not own any real property.
(b) Section 2.4.15(b) of the Disclosure Schedule lists all Leases
of real property. Owner has delivered to Buyer a true and complete copy of each
such Lease as of the Agreement Date. Each such Lease is in full force and effect
and constitutes the valid and legally binding obligation of the Company. The
Company is not in breach or default under any such Lease and, to the Knowledge
of Owner, no event has occurred or circumstance exist which, with the delivery
of notice, the passage of time or both, would constitute such a breach or
default.
(c) No condemnation proceedings are pending, or to the Knowledge
of Owner, threatened, with respect to any real property which is the subject of
a Lease.
2.4.16 Intellectual Property.
(a) Section 2.4.16(a) of the Disclosure Schedule lists all
Intellectual Property (except for readily available off-the-shelf software
having an original purchase price of less than $10,000) used in the Business, in
each case specifying whether the Intellectual Property is owned or licensed by
the Company.
(b) Except as set forth in Section 2.4.16(b) of the Disclosure
Schedule:
(i) The Company owns and possesses all right, title and
interest in and to, free and clear of any Liens other than Permitted Liens, or
has a valid, enforceable and effective license to use, all of the Intellectual
Property identified in Section 2.4.16(a) of the Disclosure Schedule;
(ii) The Company has received no Claim by any Third Party
contesting the validity, grant, registrability, enforceability, use or ownership
of any Intellectual Property identified in Section 2.4.16(a) of the Disclosure
Schedule and, to the Knowledge of Owner, no such Claim has been threatened;
(iii) To the Knowledge of Owner, no Third Party is
infringing upon the Intellectual Property identified in Section 2.4.16(a) of the
Disclosure Schedule;
(iv) To the Knowledge of Owner, the use of the Intellectual
Property identified in Section 2.4.16(a) of the Disclosure Schedule does not
infringe upon or otherwise violate the rights of any Third Party; and
(v) The Company has not brought or threatened a Claim
against any Person alleging infringement upon or any other violation of the
Intellectual Property identified in Section 2.4.16(a) of the Disclosure Schedule
or challenging any Person's ownership or use of, or the validity, enforceability
or registrability of, any Intellectual Property identified in Section 2.4.16(a)
of the Disclosure Schedule.
(c) The Company has not licensed or sublicensed its rights in any
of the Intellectual Property identified in Section 2.4.16(a) of the Disclosure
Schedule.
11
(d) Each copyright registration, patent and registered trademark
and application identified in Section 2.4.16(a) of the Disclosure Schedule is in
proper form, not disclaimed and has been duly maintained, including the
submission of all necessary filings in accordance with the legal and
administrative requirements of the appropriate jurisdictions.
2.4.17 Contracts (Other than Provider Agreements).
(a) Section 2.4.17(a) of the Disclosure Schedule lists the
following undischarged Contracts, including all amendments thereto, to which the
Company is a party:
(i) Contracts with any Governmental Entity (including the
Medicaid Contract and Medicare Contract);
(ii) All Employment Agreements;
(iii) Contracts for consulting services;
(iv) The Company policies or Contracts for the payment of
severance benefits or retention bonuses to any Employee;
(v) Contracts for the purchase of equipment or other
materials in which the purchase price of such equipment or other materials
exceeds $25,000;
(vi) Contracts for the sale of any of the Company's
equipment or other assets;
(vii) Contracts for services, other than Provider
Agreements, that provide for the expenditure of more than $25,000 annually;
(viii) Leases or subleases, either as lessee or sublessee,
lessor or sublessor, of personal property or intangibles, in which the Lease or
sublease provides for an annual rent in excess of $25,000 and has an unexpired
term as of the Closing Date in excess of one year;
(ix) Contracts, other than Provider Agreements, restricting
in any manner the Company's right to compete with any other Person or
restricting the Company's right to sell to or purchase from any other Person;
(x) Service Contracts affecting any of the Company's assets
in which the annual service or maintenance charge exceeds $25,000 and the
unexpired term as of the Closing Date exceeds one year;
(xi) Contracts for the advertisement, display or promotion
of any products or services which cannot be canceled by the Company without
payment or penalty upon notice of 60 days or less;
(xii) Loan or credit agreements, pledge agreements, notes,
security agreements, mortgages, debentures, indentures, factoring agreements or
letters of credit;
12
(xiii) Guarantees, performance, bid or completion bonds, or
surety or indemnification agreements;
(xiv) Contracts involving a sharing of profits, losses,
costs or liabilities by the Company and another Person; or
(xv) Any other Contracts, other than Provider Agreements,
that provide for the receipt or expenditure of more than $25,000 or that expire,
or may be renewed at the option of any Person other than the Company so as to
expire, more than one year after the Agreement Date.
(b) All Designated Contracts are in full force and effect and are
valid and enforceable in accordance with their terms. The Company is, in all
material respects, in compliance with all terms and requirements of each
Designated Contract. To the Knowledge of Owner, (i) each other Person who or
which is party to a Designated Contract is in material compliance with the terms
and requirements of such Contract, and (ii) no event has occurred or
circumstance exists which (with or without notice or lapse of time) may
contravene, conflict with or result in a violation or breach of, or give the
Company or any other Person the right to declare a default or exercise any
remedy under, or to accelerate the maturity or performance of, or to cancel,
terminate or modify any Designated Contract. There are no renegotiations,
attempts to renegotiate or outstanding rights to negotiate any amount to be paid
or payable to or by the Company under any Designated Contract other than with
respect to non-material amounts in the Ordinary Course of Business, and no
Person has made a written demand for such renegotiation. The Company has not
released or waived any of its rights under any Designated Contract.
(c) Except for Designated Contracts and Provider Agreements,
there are no material Contracts relating to the Business.
(d) Except as set forth in Section 2.4.17(d) of the Disclosure
Schedule, the Company has delivered to Buyer (i) a correct and complete copy of
each written Designated Contract, including any amendments thereto, and (ii) a
written description of any oral Designated Contract.
2.4.18 Litigation. Except as set forth in Section 2.4.18 of the
Disclosure Schedule, the Company is not (a) subject to any outstanding
injunction, judgment, order, decree or ruling by a Governmental Entity, or (b) a
party to or the subject of, or to the Knowledge of Owner, threatened to be made
a party to or the subject of, any action, suit, proceeding, hearing or
investigation in or before any Governmental Entity in which the action, suit,
proceeding, hearing or investigation has had or would reasonably be likely to
have a Material Adverse Effect.
2.4.19 [Intentionally Left Blank]
2.4.20 Employee Benefits. Other than a part-time medical director, the
Company has no employees, and the Company has no Benefit Plan, and has no
commitment to create any Benefit Plan.
2.4.21 Environmental, Health and Safety Matters. The Company is in
compliance in all material respects with all Environmental, Health and Safety
Requirements.
13
The Company has not received any written notice, demand, request for
information, citation, summons, report or other information regarding any actual
or alleged violation by the Company of any Environmental, Health and Safety
Requirement.
2.4.22 Certain Business Relationships. No officer or manager of the
Company (a) owns any property or assets necessary for the Business, or (b) has
any material ownership interest in any Person who or which (i) has business
dealings with the Company, or (ii) competes with the Business.
2.4.23 Undisclosed Liabilities. The Company has no material
liabilities or obligations of any nature, whether absolute, contingent or
otherwise, other than liabilities or obligations (a) accrued or reserved for on
the balance sheets included in the Financial Statements, (b) set forth in the
Disclosure Schedule, or (c) incurred after the date of most recent balance sheet
in the Ordinary Course of Business.
2.4.24 Labor Matters.
(a) The Company is not a party to or bound by any collective
bargaining agreement or similar agreement with any union or labor organization
and there are no labor strikes, slowdowns, work stoppages or lockouts currently
involving the Employees.
(b) To the Knowledge of Owner, (i) no union or labor organization
claims to represent any Employees, and (ii) there is no activity by any labor
organization to organize any Employees.
(c) Except as set forth in Section 2.4.24(c) of the Disclosure
Schedule, (i) there are no charges with respect to or relating to any Employee
pending before the Equal Employment Opportunity Commission or any other
Governmental Entity responsible for the prevention of unlawful employment
practices, and (ii) the Company has not received notice of the intent of any
Governmental Entity responsible for the enforcement of labor or employment laws
to conduct an investigation with respect to or relating to any Employee.
(d) The Company has properly classified (i) all Persons providing
services to the Company as employees or independent contractors, as applicable,
and (ii) all Employees as exempt or non-exempt, as applicable, under the Fair
Labor Standards Act or similar Law.
(e) Section 2.4.24(e) of the Disclosure Schedule lists the names
of all Employees as of the Agreement Date together with their respective base
salaries and positions.
(f) No Employee has any claim against the Company on account of
or for: (i) overtime pay other than overtime pay for the payroll period covering
the Agreement Date, (ii) wages or salaries other than wages or salaries for the
payroll period overlapping the Agreement Date, or (iii) vacations, sick leave,
time off or pay in lieu of vacation, sick leave or time off other than vacation,
sick leave or time off (or pay in lieu thereof) earned in the 12 month period
immediately prior to the Agreement Date.
14
(g) The Company has made all required payments to the relevant
unemployment compensation reserve account with the appropriate governmental
departments with respect to its employees and such accounts have positive
balances.
2.4.25 Subsidiaries. The Company has no subsidiaries.
2.4.26 Suppliers. Section 2.4.26 of the Disclosure Schedule sets forth
the names and addresses of the ten largest non-health care related suppliers of
the Business based on the dollar volume of purchases of goods or services
provided to the Company (whether contracting directly with Company or
contracting through Company's Affiliates) during 2006 and 2007, and such
suppliers represent eighty percent (80%) or more of all of the suppliers of the
Business based on dollar volume. Except as identified in Section 2.4.26 of the
Disclosure Schedule, the Company has not received any written notice that any
such supplier will not sell supplies, merchandise or other goods to the Company
at any time after the Closing Date on terms and conditions substantially similar
to those currently in effect, subject only to general and customary price
increases.
2.4.27 Insurance. Section 2.4.27 of the Disclosure Schedule lists the
policies of fire and casualty, liability and other forms of insurance maintained
by the Company and in such amounts, with such deductibles and against such risks
and losses identified therein. All such policies are in full force and effect,
all premiums due and payable thereon have been paid and no notice of
cancellation or termination has been received with respect to any such policy.
2.4.28 Conduct of Business. Since January 1, 2008, (a) the Company has
conducted the Business only in the Ordinary Course of Business, (b) there has
not been any Material Adverse Effect, (c) there has been no non-renewal or
material amendment of the Medicaid Contract or Medicare Contract, (d) there has
been no physical damage, destruction or other casualty loss (whether or not
covered by insurance) affecting any of the owned or leased real or personal
property or equipment of the Company in an amount exceeding $25,000,
individually or in the aggregate, and (e) the Company has not taken or permitted
to be taken any action which, if proposed to be taken on or after the Agreement
Date, would require the consent of Buyer pursuant to Section 4.1.
2.4.29 Statutory Surplus. As of the Closing Date, the Company will be
in full compliance with all Laws applicable to the adequacy and maintenance of
its statutory surplus.
2.4.30 Bank Accounts. Section 2.4.30 of the Disclosure Schedule lists
(a) the name of each bank, safe deposit the Company or other financial
institution in which the Company has an account, lock box or safe deposit box,
(b) the names of all Persons authorized to draw thereon or to have access
thereto, and (c) all instruments or agreements to which the Company is a party
as an endorser, surety or guarantor other than checks endorsed for collection or
deposit in the Ordinary Course of Business.
2.4.31 Providers and Provider Agreements.
(a) Section 2.4.31(a) of the Disclosure Schedule lists all
Provider Agreements.
15
(b) The Company has compensated and currently compensates each
Provider for covered services provided to Enrollees in accordance with the rates
and fees set forth in the applicable Provider Agreement and the Company's
standard payment policies and procedures.
(c) Except as set forth in Section 2.4.31(c) of the Disclosure
Schedule, there are no renegotiations, attempts to renegotiate or outstanding
rights to negotiate any amount to be paid or payable to or by the Company under
any Provider Agreement other than with respect to non-material amounts in the
Ordinary Course of Business.
2.4.32 Payments under Medicaid Contract. Except as set forth in
Section 2.4.32 of the Disclosure Schedule, the Company is not a party to or the
subject of any action, suit, proceeding, hearing or investigation in or before
the State Agency related to the recovery of payments received by the Company
from the State Agency under the Medicaid Contract and, to the Knowledge of
Owner, the Company has not been threatened to be made a party to or the subject
of any such action, suit, proceeding, hearing or investigation.
2.4.33 Payments under Medicare Contract. Except as set forth in
Section 2.4.33 of the Disclosure Schedule, the Company is not a party to or the
subject of any action, suit, proceeding, hearing or investigation in or before
CMS related to the recovery of payments received by the Company from CMS under
the Medicare Contract and, to the Knowledge of Owner, the Company has not been
threatened to be made a party to or the subject of any such action, suit,
proceeding, hearing or investigation.
2.4.34 Commercial Bribery. Neither the Company nor any of the
Employees, former employees or current or officers, managers or Representatives
has paid or made, directly or indirectly, with respect to the Business, (a) any
bribes or kickbacks, (b) illegal political contributions, (c) payments from the
Company funds not recorded on the books and records of the Company, (d) payments
from the Company funds to governmental officials in their individual capacities
for the purpose of affecting their action or the action of the Governmental
Entity they represent to obtain favorable treatment in securing business or
Licenses or to obtain special concessions, or (e) illegal payments from the
Company funds to obtain or retain business.
2.4.35 Update of Information. Each of the representations made by the
Company in this Section 2.4 shall be deemed made and given on the Agreement Date
and continuously thereafter until the Closing. During the period from the
Agreement Date until the Closing, the Company shall give Buyer within a
reasonable time after the Company determines that any representation made in
this Section 2.4 would cease to be correct if such representation were made on
such date, contains any untrue statement of a material fact or omits to state a
material fact necessary to make such representation not misleading. To be
effective, each such notice shall (a) identify, by section reference, the
representation as to which the notice relates, (b) correctly restate the
representation, and (c) if applicable, be accompanied by an amendment to any
Section of the Disclosure Schedule that identifies the exceptions to the
representation.
2.5 SURVIVAL OF REPRESENTATIONS AND WARRANTIES. The representations and
warranties of the Parties made in this Agreement shall survive the Closing for a
period of eighteen (18) months, except that (i) in the case of actual fraud by
the Company or Owner such
16
fraudulent representations and warranties shall survive until the expiration of
the applicable statute of limitations (taking into account all extensions
thereof), and (ii) the representations and warranties set forth in Section
2.4.14 shall survive the Closing until the expiration of the applicable statute
of limitations (taking into account all extensions thereof).
ARTICLE III
CONDUCT PRIOR TO CLOSING
3.1 OBLIGATIONS OF THE COMPANY.
3.1.1 Conduct of Business. During the period from the Agreement Date
through the Closing Date, except as may be expressly contemplated by this
Agreement, set forth in Section 3.1 of the Disclosure Schedule, or consented to
in writing by Buyer, the Company shall (and the Owner agrees to cause the
Company to take the actions set forth herein):
(a) Continue the Ordinary Course of Business;
(b) Use commercially reasonable efforts to maintain and preserve
intact the Business and maintain the ordinary and customary relationships of the
Company with its Providers, Enrollees, Employees and suppliers;
(c) Not amend the Company Articles, bylaws, or any other
organizational or governing document of the Company;
(d) Not issue any equity or ownership interests or other
securities convertible or exchangeable into equity or ownership interests in the
Company or any options, warrants or other rights to purchase any such equity or
ownership interests or any securities convertible into or exchangeable for such
equity or other ownership interests;
(e) Not recognize, approve or participate in the sale, transfer,
pledge, disposition or other encumbrance of any of the Shares or any other
securities or equity or ownership interests in the Company;
(f) Not declare, set aside or pay any distribution with respect
to any of the Shares or any other securities or equity or ownership interests in
the Company that will result in cash and cash equivalents at the Company falling
below the Minimum Net Worth;
(g) Not repurchase, redeem or otherwise acquire directly or
indirectly any of the Shares or any other securities or equity or ownership
interests in the Company;
(h) Not change in any material respect any of the accounting
methods used with respect to the Business unless required by GAAP or SAP;
(i) Not transfer, sell, lease, license, mortgage, pledge, grant
any security interest in, create any Lien, other than Permitted Liens, upon or
otherwise dispose of any of the assets or properties of the Business other than
in the Ordinary Course of Business;
17
(j) Not sell, transfer, pledge, modify, disclose, dispose of,
abandon or permit to lapse any right under or respecting, or enter into any
settlement regarding the breach or infringement of, any Intellectual Property
used in the Business;
(k) Not (i) make any loans, advances or capital contributions to,
or investments in, any Person, or (ii) incur, assume or guarantee any
indebtedness for borrowed money other than in the Ordinary Course of Business;
(l) Not purchase or otherwise acquire any material assets on
behalf of the Company or make commitments therefore involving the expenditure of
more than $150,000 individually and $300,000 in the aggregate per calendar
month, other than in the ordinary course of business;
(m) Not merge or consolidate with, purchase all or any
substantial part of the assets of, or otherwise acquire, any Person;
(o) Other than in the Ordinary Course of Business, not (i) enter
into any material Contract with respect to the Business, or (ii) modify in any
material respect, amend in any material respect or terminate any Designated
Contract;
(p) Not enter into any Contract with respect to the Business
which imposes non-competition, non-solicitation, exclusive dealing or other
similar obligations or limitations on the Company;
(q) Not enter into any Contract, or amend any Contract, with
Owner or any of Owner's Affiliates;
(r) Not settle or compromise any material litigation with respect
to the Business or waive, release or assign any material rights or Claims with
respect to the Business;
(s) Not (i) settle or compromise any Tax liability, (ii) agree to
any adjustment of any Tax attribute, (iii) make, change or revoke any election
with respect to Taxes, (iv) surrender any right to claim, or file a Claim for, a
refund of Taxes, (v) consent to any extension or waiver of the statute of
limitations period applicable to any Taxes or Tax Return, (vi) amend any Tax
Return, (vii) enter into any closing or other agreement with respect to Taxes,
(viii) grant any power of attorney with respect to Taxes, or (ix) except insofar
as may be required by a change in GAAP, SAP or applicable Law, change accounting
methods, principles or practices for Tax or accounting purposes;
(t) Not fail to maintain or renew any Licenses;
(u) Not reduce the amount of any insurance coverages identified
in Section 2.4.27 of the Disclosure Schedule or fail to renew any such insurance
policies; and
(v) Use commercially reasonable best efforts to refrain from
taking (or failing to take) any other action which will result, or reasonably
could be expected to result, in the failure to satisfy any of the conditions set
forth in Section 4.3.
18
3.1.2 Full Access. During the period from the Agreement Date through
the Closing Date, the Company shall permit Representatives of Buyer to have full
access at all reasonable times, and in a manner so as not to interfere with the
normal business operations of the Company, to all premises, properties,
personnel, books, records, Tax Returns, Contracts and documents of or pertaining
to the Company or the Business. Further, the Company shall deliver to Buyer as
soon as possible after completion, the unaudited (or audited, as the case may
be) Financial Statements actually prepared by the Company for all periods from
the Agreement Date through the Closing. Any information obtained by Buyer
pursuant to the access accorded under this Section 3.1.2 shall be held by Buyer
subject to the provisions of the Confidentiality Agreement.
3.1.3 Standstill. During the period from the Agreement Date through
the Closing Date, the Company shall not, and the Company shall cause its
officers, Employees, managers and agents not to, solicit, initiate or encourage
the initiation of inquiries or proposals from, provide any Confidential
Information to or participate in any discussions or negotiations or cooperate
with any Person (other than Buyer, its Affiliates and their respective
Representatives) which could involve, directly or indirectly, any sale by (a)
the Company of all or substantially all of its assets, or (b) Owners of any of
its ownership interests in the Company.
3.2 OBLIGATIONS OF OWNER. During the period from the Agreement Date through
the Closing Date, Owner shall not, and Owner shall cause its officers,
employees, directors and agents not to, (a) solicit, initiate or encourage the
initiation of inquiries or proposals from, provide any Confidential Information
to or participate in any discussions or negotiations or cooperate with any
Person (other than Buyer, its Affiliates and their respective Representatives)
which could involve, directly or indirectly, any sale by (i) Owner of any of its
ownership interests in the Company, or (ii) the Company of all or substantially
all of its assets, and (b) amend the Company Articles, bylaws, or any other
organizational or governing document of the Company.
3.3 JOINT OBLIGATIONS.
3.3.1 Best Efforts. During the period from the Agreement Date through
the Closing Date, each Party shall use its best efforts to take, or cause to be
taken, all actions, and to do, or cause to be done, all things reasonably
necessary, desirable or appropriate, including under applicable Laws, to fulfill
its obligations under this Agreement and to make effective the transactions
contemplated by this Agreement.
3.3.2 Governmental Approvals/Consents.
(a) Promptly following the Agreement Date, Owner and Buyer shall
file with the Federal Trade Commission and the Department of Justice the
notification required to be filed with respect to the transactions contemplated
by this Agreement under the HSR Act. Buyer and Owner shall jointly pay the
filing fees associated with the filing of such notification under the HSR Act.
Each Party shall respond promptly to any requests for additional information
made by such agencies and shall cooperate with the other Parties in making such
filings and in responding to such information requests.
19
(b) Promptly following the Agreement Date, each of Owner and
Buyer shall file such documents as are necessary to obtain the approval of the
DOI to the transactions contemplated by this Agreement. Each Party shall respond
promptly to any requests for additional information made by the DOI and shall
cooperate with the other Parties in making such filings and in responding to
such information requests.
(c) Promptly following the Agreement Date, the Company shall
apprise the State Agency (and to the extent required, CMS) of the execution of
this Agreement and shall file such documents as are necessary to obtain any
consent from, or make any disclosures to, the State Agency (and to the extent
required, CMS) regarding the transactions contemplated by this Agreement.
(d) With respect to the obligations of Buyer, Owner and the
Company in Sections 3.3.2(a), 3.3.2(b) and 3.3.2(c), each of them shall (i)
promptly notify the other Parties of any written communication received from any
Governmental Entity, (ii) if practicable, permit the other's respective counsel
to review in advance any proposed written communication to any such Governmental
Entity and incorporate the reasonable comments of such counsel, (iii) not
participate in any substantive meetings or discussions with any such
Governmental Entity in respect of any filing, investigation or inquiry
concerning this Agreement or the transactions contemplated hereby without
consulting with the other's respective counsel in advance, (iv) to the extent
permitted by such Governmental Entity, give the other Parties the opportunity to
participate in any such meetings or discussions, and (v) furnish the other
Parties' respective counsel with copies of all correspondence, filings and
written communications to or from any such Governmental Entity.
3.4 AMENDED GOVERNING DOCUMENTS. If required by DOI or the State Agency, or
if requested by Buyer, Owner and Company shall file Amended Articles. Buyer and
Owner shall reasonably agree on such Amended Articles.
ARTICLE IV
CONDITIONS TO CLOSING
4.1 CONDITIONS TO BUYER'S OBLIGATIONS. Buyer's obligation to consummate the
transactions to be performed by it in connection with the Closing is subject to
satisfaction of each of the following conditions or the waiver thereof in
writing by Buyer prior to the Closing:
4.1.1 Receipt by Buyer of all deliverables required from the Company
and Owner in Article I;
4.1.2 No injunction, judgment, order, decree, ruling or charge shall
be in effect which prevents the Closing;
4.1.3 No event resulting in a Material Adverse Effect has occurred;
4.1.4 The requisite waiting period, if any, under the HSR Act shall
have expired or terminated;
20
4.1.5 The DOI shall have approved the transactions contemplated by
this Agreement;
4.1.6 The Company shall have and maintain the Minimum Net Worth as of
the Closing;
4.1.7 The State Agency has awarded one or more Full-Risk Medicaid
Contracts to the Company at reimbursement levels acceptable to Buyer in its sole
discretion; and
4.1.8 All corporate approvals (including the unconditional approval of
UAHC's shareholders and board of directors) of this Agreement and all
transactions contemplated herein (including the option to acquire the remaining
Shares as set forth in the Shareholder Agreement), shall have been obtained in
accordance with all applicable federal and state statutes and regulations
related to the sale of all or substantially all of the assets of a corporation.
4.2 CONDITIONS TO OWNER'S OBLIGATIONS. Owner's obligation to consummate the
transactions to be performed by it in connection with the Closing is subject to
satisfaction of each of the following conditions or the waiver thereof in
writing by Owner prior to the Closing:
4.2.1 Receipt by Owner of all deliverables required from Buyer in
Article 1;
4.2.2 No injunction, judgment, order, decree, ruling or charge shall
be in effect which prevents the Closing;
4.2.3 The requisite waiting period, if any, under the HSR Act shall
have expired or terminated;
4.2.4 The DOI shall have approved the transactions contemplated by
this Agreement;
4.2.5 All required consents from, or disclosures to, the State Agency
shall have been received or made; and
4.2.6 The State Agency has awarded one or more Full-Risk Medicaid
Contracts to the Company at reimbursement levels acceptable to Owner in its sole
discretion.
4.3 CONDITIONS TO THE COMPANY'S OBLIGATIONS. The Company's obligation to
consummate the transactions to be performed by it in connection with the Closing
is subject to satisfaction of each of the following conditions or the waiver
thereof in writing by the Company prior to the Closing:
4.3.1 No injunction, judgment, order, decree, ruling or charge shall
be in effect which prevents the Closing;
4.3.2 The requisite waiting period, if any, under the HSR Act shall
have expired or terminated;
21
4.3.3 The DOI shall have approved the transactions contemplated by
this Agreement; and
4.3.4 All required consents from, or disclosures to, the State Agency
shall have been received or made.
ARTICLE V
POST-CLOSING COVENANTS
5.1 EXECUTION OF DOCUMENTS. In the event any further action is necessary or
desirable to carry out the purposes of this Agreement following the Closing
Date, each Party shall take such further action, including the execution and
delivery of such further instruments and documents, as the other Party
reasonably may request, all at the sole cost and expense of the requesting Party
unless the requesting Party is entitled to indemnification for such action under
this Agreement.
5.2 BOOKS AND RECORDS. Following the Closing Date, the Company shall retain
(a) for the greater of (i) ten years, and (ii) the period required by applicable
Laws, all medical and financial records relating to medical services provided to
Enrollees, including for examination and audit by the State Agency and other
authorized Governmental Entities, (b) until the applicable Tax statutes of
limitation (including periods of waiver) have expired, all books, records and
other documents required to support or document information contained on Tax
Returns filed prior to the Closing Date or covering the period ending on the
Closing Date, and (c) until the period a Claim can be asserted under Article VI,
all books, records and other documents required to support or document the
assertion or defense of any such Claim.
5.3 FINANCIAL STATEMENTS. Within ninety (90) days after the Closing, the
Company shall deliver complete and accurate copies of Financial Statements for
the twelve months ending as of the Closing Date (or if the Closing Date is not
the first of a month, then the Financial Statements shall be for the twelve
months ending as of the first day of the next month immediately after the
Closing Date). The Financial Statements shall be prepared in accordance with
GAAP that accurately reflects the books and records of the Business and present
fairly in all material respects the financial condition of the Company as of the
Closing Date. In the event Buyer does not accept such Financial Statements
within thirty (30) days of delivery, the parties shall meet and confer for an
additional thirty (30) days and resolve any differences regarding such Financial
Statements. In the event the parties cannot resolve any such differences, the
Company shall obtain an audit of such Financial Statements from the current
auditor of the Company (or an Affiliate), and such audit shall be conclusive and
binding upon all of the parties.
ARTICLE VI
INDEMNIFICATION
6.1 INDEMNIFICATION BY OWNER. Subject to Section 6.5, from and after the
Closing Date, Owner shall indemnify and hold Buyer, its Affiliates (including
the Company) and their respective officers, directors, agents and employees
harmless from and against any and all Claims to the extent such Claims arise
from or are related to (a) a breach by Owner or the Company of any
representation or warranty of Owner or the Company in this Agreement, (b) any
22
failure by Owner to perform or comply with any of the obligations of Owner in
this Agreement, (c) any failure of the Company to perform or comply with any of
its obligations under this Agreement, and (d) any Pre-Closing Liabilities.
6.2 INDEMNIFICATION BY BUYER. Subject to Section 6.5.1, from and after the
Closing Date, Buyer shall indemnify and hold Owner, its Affiliates (including
the Company) and their respective officers, directors, agents and employees
harmless from and against any and all Claims to the extent such Claims arise
from or are related to (a) a breach by Buyer of any representation or warranty
of Buyer in this Agreement, and (b) any failure by Buyer to perform or comply
with any of the obligations of Buyer in this Agreement.
6.3 NOTICE OF CLAIM FOR INDEMNIFICATION. Each Indemnitee shall notify the
indemnifying Party in writing of any Claim that the Indemnitee has determined
has given or could give rise to a Claim for indemnity under this Agreement (such
written notice being hereafter referred to as a "Notice of Claim") promptly
after the Indemnitee has made such a determination. In amplification of the
foregoing:
6.3.1 A Notice of Claim shall specify in reasonable detail the nature
and estimated amount of any such Claim that the Indemnitee believes does, or
could, give rise to a right of indemnification hereunder.
6.3.2 Failure of an Indemnitee timely to give a Notice of Claim shall
not release the indemnifying Party of its indemnity obligations except to the
extent that such failure directly causes or results in additional damages,
losses, liabilities or expenses, in which case the indemnifying Party shall be
released of its indemnity obligations only to the extent of such additional
damages, losses, liabilities or expenses.
6.3.3 If the Indemnitee settles or compromises any such action or
Claim prior to giving a Notice of Claim, the indemnifying Party shall be
released of its indemnity obligations to the extent that the settlement or
compromise was not made with the prior written consent of such indemnifying
Party.
6.4 DEFENSE OF UNDISPUTED CLAIMS. The indemnifying Party shall defend, in
good faith and at its expense, each Claim encompassed by a Notice of Claim which
it does not dispute. The Indemnitee, at its expense, shall have the right, but
not the obligation, to participate in the defense of such Claim, it being
understood thereby that settlement of such Claim shall, to the extent the
settlement fully resolves such Claim, relieve the indemnifying Party from any
requirement further to defend such Claim. In amplification of the foregoing:
6.4.1 So long as the indemnifying Party is defending in good faith any
such Claim, the Indemnitee shall not settle or compromise the Claim without the
prior written consent of the indemnifying Party.
6.4.2 The Indemnitee shall make available to the indemnifying Party
and its Representatives all records and other materials reasonably required for
use in defending against or otherwise contesting the Claim and shall cooperate
in good faith with the indemnifying Party; the indemnifying Party shall keep the
Indemnitee informed regarding the status and progress of the Claim and defense
of the Claim.
23
6.4.3 If the indemnifying Party does not defend any Claim encompassed
by a Notice of Claim, the Indemnitee with respect thereto shall have no
obligation to do so, but the Indemnitee shall be permitted to do so at the
expense of the indemnifying Party without releasing or compromising the
Indemnitee's rights against the indemnifying Party in respect of the Claim and,
in such event, the Indemnitee may settle the Claim in any fashion determined by
the Indemnitee in its sole discretion and the indemnifying Party shall be fully
liable to the Indemnitee with respect thereto.
6.5 DISPUTED CLAIMS FOR INDEMNIFICATION.6.5.1 In the event an indemnifying
Party disputes the validity or extent of any request for indemnification under
this Article VI and such dispute is not resolved amicably by or among the
indemnifying Party and the Indemnitee(s), such dispute shall be resolved
pursuant to Section 8.13.
6.6 PAYMENT BY THE COMPANY. In the event the payment of any Claim is made
by the Company, the indemnifying Party shall contribute an amount equal to such
payment to the capital of the Company and shall not receive any additional
Shares or interest in the Company.
6.7 EXCLUSIVE REMEDY. After the Closing, except for the provisions of
Article II, the remedies provided in this Article VI shall be exclusive and
enforceable in lieu of all other remedies for any breach of any representation,
warranty, covenant, obligation, agreement or other provision of this Agreement.
6.8 LIMITATIONS. Notwithstanding anything in this Agreement to the
contrary, (a) each of Buyer and Owner shall be entitled to a credit or offset
against any liability under this Article VI in the amount of $250,000, and (b)
in no event shall the aggregate liability of Buyer or Owner arising under this
Article VI exceed the sum of the Purchase Price.
ARTICLE VII
TERMINATION
7.1 TERMINATION OF AGREEMENT. This Agreement may be terminated at any time
prior to the Closing by:
7.1.1 Mutual written consent of Buyer and Owner;
7.1.2 Buyer or Owner immediately upon written notice to the other
Parties if (a) any Governmental Entity shall have enacted, promulgated or issued
any statute, rule, regulation, ruling, writ, order or injunction which would
prohibit or render illegal the consummation of the transactions contemplated by
this Agreement, or (b) any authorizations, consents or approvals of any
Governmental Entity, including the DOI, the State Agency and the Federal Trade
Commission (with respect to the HSR Act), which are required to permit the
Closing to take place pursuant to the provisions of this Agreement are denied or
granted with conditions or requirements which are materially adverse to the
terminating Party and all appeals and means of appeal therefrom have been
exhausted;
7.1.3 Buyer if a material breach of any provision of this Agreement
has been committed by Owner or the Company and such breach has not been (a)
waived in writing by Buyer, (b) cured by the breaching Party to the reasonable
satisfaction of Buyer within 15
24
Business Days after service by Buyer of a written notice upon the breaching
Party which describes the nature of such breach with reasonable particularity
(with a copy of such notice being provided to all Parties), or (c) the
reimbursement rates proposed by the State Agency for services under the
Full-Risk Medicaid Contract(s) are not adequate as determined by Buyer in its
sole discretion;
7.1.4 Owner if a material breach of any provision of this Agreement
has been committed by Buyer and such breach has not been (a) waived in writing
by Owner, or (b) cured by Buyer to the reasonable satisfaction of Owner within
15 Business Days after service by Owner of a written notice upon Buyer which
describes the nature of such breach with reasonable particularity (with a copy
of such notice being provided to all Parties), or (c) the reimbursement rates
proposed by the State Agency for services under the Full-Risk Medicaid
Contract(s) are not adequate as determined by Owner in its sole discretion; or
7.1.5 Buyer or Owner immediately upon written notice to the other
Parties if the Closing has not occurred on the earlier of (i) a final decision
by the State Agency to award the Full-Risk Medicaid Contracts to an unrelated
third party or parties, or (ii) July 1, 2008.
7.2 EFFECT OF TERMINATION. In the event this Agreement is terminated
pursuant to Section 7.1, all rights and obligations of the Parties hereunder
shall terminate without any liability of any Party to the other Parties;
provided, however, (a) a Party in breach of this Agreement shall remain liable
for damages resulting from such breach, and (b) the provisions of this Section
7.2, 8.2, 8.10 and 8.13 shall survive any termination of this Agreement.
ARTICLE VIII
MISCELLANEOUS
8.1 CONSTRUCTION.
8.1.1 The Parties have participated jointly in the negotiation and
drafting of this Agreement. In the event an ambiguity or question of intent or
interpretation arises, this Agreement shall be construed as if drafted jointly
by the Parties and no presumption or burden of proof shall arise favoring or
disfavoring any Party by virtue of the authorship of any of the provisions of
this Agreement.
8.1.2 Unless the context of this Agreement otherwise requires, the
following shall be applicable herein: (a) words using the singular or plural
number also include the plural or singular number, respectively; (b) headings
and titles of Articles, Sections, Exhibits and Sections of the Disclosure
Schedule are included for convenience only and shall not be considered a part of
this Agreement when interpreting or enforcing this Agreement; (c) references to
Sections, Articles and Exhibits are to the applicable Sections, Articles and
Exhibits of this Agreement; (d) use of the word "including" shall be
illustrative rather than exclusive and shall be interpreted in all instances to
mean "including, without limitation;" and (e) the predicate of any noun or
pronoun shall be the immediately preceding noun.
8.2 PRESS RELEASES AND PUBLIC ANNOUNCEMENTS. Without the prior written
approval of each of the Parties, no Party, either prior to or after the Closing,
shall issue, or consent to or cooperate with the issuance by a third party of, a
press release or other public announcement
25
regarding (a) the execution of this Agreement, or (b) any or all of the
transactions contemplated by this Agreement; provided, however, nothing herein
shall preclude a Party from complying with its or his respective
responsibilities under applicable Laws.
8.3 ENTIRE AGREEMENT. Except as set forth in the Confidentiality Agreement,
this Agreement (a) constitutes the entire understanding and agreement of the
Parties with respect to the subject matter hereof, and (b) supersedes all prior
negotiations, correspondence, discussions and agreements, written or oral, among
the Parties with respect to the subject matter hereof.
8.4 NO THIRD-PARTY BENEFICIARIES. None of the provisions contained in this
Agreement are intended by the Parties, nor shall they be deemed, to confer any
benefit on any person or entity not a Party to this Agreement other than any
Person entitled to indemnification under Article VI.
8.5 FURTHER ASSURANCES. From and after the Agreement Date, each Party shall
execute and deliver such additional documents and other instruments and do all
such other acts and things as reasonably may be necessary or otherwise
appropriate to effect and implement the transactions contemplated by this
Agreement.
8.6 SUCCESSORS AND ASSIGNS. All of the terms and provisions of this
Agreement shall be binding upon, inure to the benefit of and be enforceable by
the respective successors, assigns and heirs of the Parties.
8.7 ASSIGNMENT. No Party shall have the right to assign this Agreement
without the prior written consent of each of the other Parties and any attempted
assignment of this Agreement by any of the Parties without such prior written
consents shall be of no force or effect.
8.8 AMENDMENT. This Agreement may not be amended or modified unless
pursuant to a written instrument which refers specifically to this Agreement and
is executed by the Parties.
8.9 NOTICES.
8.9.1 Any notice or other instrument which is required or permitted to
be given under this Agreement to a Party shall be deemed sufficiently given if
(a) delivered personally, (b) sent by registered or certified U.S. Mail, return
receipt requested and postage prepaid, (c) sent by national overnight delivery
service (such as FedEx) with charges prepaid, or (d) sent by telefax, in each
instance, addressed and delivered personally or sent for delivery as set forth
on Exhibit B attached hereto, subject, however, to changes as provided in
Section 8.9.2.
8.9.2 Each Party shall have the right, from time-to-time, to change
(a) its or his address, (b) the person to whose attention notices and other
communications are to be given, (c) its or his telefax number, and (d) the
entity, and particulars regarding such entity, to which copies of notices and
other communications to such Party are to be given, in each instance by written
notice thereof to the other Parties.
8.9.3 Any notice or copy thereof (a) personally delivered shall be
deemed given when received by the intended recipient, (b) sent by telefax shall
be deemed given when so sent
26
to the intended recipient, provided the original of such notice or copy thereof
is given by another means specified in Section 8.9.1, and (c) sent by registered
or certified U.S. Mail or an overnight delivery service shall be deemed given on
the earlier of the date of receipt by the intended recipient or three days after
the date on which such notice or copy thereof is sent.
8.10 EXPENSES AND ATTORNEYS' FEES. Each Party shall be responsible
exclusively for its own costs and expenses relating to (i) the negotiation and
preparation of this Agreement, (ii) the conduct of any due diligence in
connection with the transactions contemplated by this Agreement, (iii) any
actions taken to consummate the transactions contemplated by this Agreement, and
(iv) fulfillment of its obligations under this Agreement, in each instance
whether the Closing occurs, and (b) in no event shall any Party be responsible
for the fees of, or the costs and expenses incurred by, a Representative of
another Party.
8.11 WAIVERS. No consent or waiver, express or implied, by any Party to or
for any breach or default by any other Party(ies) or the performance by any
other Party(ies) of their obligations under this Agreement shall be deemed or
construed to be a consent or waiver to or of any other breach or default in the
performance by such Party(ies) of the same or any other obligations of such
Party(ies) hereunder. To be effective, all such consents and waivers shall be in
writing and executed by the Party(ies) giving the consent or waiver. All such
consents and waivers shall be construed strictly. Except to the extent expressly
provided to the contrary herein, failure on the part of any Party to complain of
any act or failure to act of another Party(ies) or to declare another Party(ies)
in default, irrespective of how long such failure continues, shall not
constitute a waiver by such Party of its rights hereunder.
8.12 SEVERABILITY. If any term, provision, condition or covenant of this
Agreement or the application thereof to any Party or circumstance shall be held
to be invalid or unenforceable to any extent in any jurisdiction, the remainder
of this Agreement and the application of such term, provision, condition or
covenant in any other jurisdiction or to persons or circumstances other than
those as to whom or which it is held to be invalid or unenforceable, shall not
be affected thereby, and each term, provision, condition and covenant of this
Agreement shall be valid and enforceable to the fullest extent permitted by Law.
8.13 BINDING ARBITRATION. Any Claim by a Party or an Indemnitee against
another Party or Indemnitee, inclusive of a dispute under Article VI, arising
out of or relating to this Agreement or the breach thereof which is not resolved
amicably by the parties involved in the Claim shall be resolved exclusively by
arbitration in accordance with the following provisions:
8.13.1 Arbitration shall (a) take place in Memphis, Tennessee, and (b)
be administered by the American Arbitration Association.
8.13.2 Petitioner(s) shall indicate intent to commence arbitration of
a Claim by giving written notice of such intent to the Respondent(s).
8.13.3 If the Petitioner(s) and Respondent(s) are unable to resolve
the Claim within 15 Business Days following the receipt by the Respondent(s) of
the notice identified in Section 8.13.2, arbitration shall commence upon the
delivery by the Petitioner(s) to the Respondent(s) of a petition complying with
the Arbitration Rules and setting forth at a minimum
27
(a) the acts or omissions complained of, (b) the Section or Sections of this
Agreement breached or otherwise involved, and (c) the relief sought. The
Respondent(s) shall respond to such petition in conformity with the Arbitration
Rules and counterclaims and cross-petitions shall be permitted if timely filed
and served.
8.13.4 The arbitration shall be conducted in conformance with the
Arbitration Rules except as otherwise provided in this Section 8.13; provided,
however, (a) the Petitioner(s) and Respondent(s) may provide any instructions to
the arbitrator(s) which deviate from the Arbitration Rules as the Petitioner(s)
and Respondent(s) may mutually agree, and (b) unless the Petitioner(s) and
Respondent(s) mutually agree otherwise, they shall have the right to conduct
discovery in any manner and to the extent authorized by the Federal Rules of
Civil Procedure as interpreted by the Federal courts in the Western District of
Tennessee.
8.13.5 If the Petitioner(s) and Respondent(s) are able to agree upon a
single arbitrator within ten Business Days following commencement of the
arbitration, such individual shall serve as the arbitrator.
8.13.6 If the Petitioner(s) and Respondent(s) are unable to agree
timely upon a single arbitrator, there shall be three arbitrators designated as
follows: (a) Petitioner(s) shall designate one arbitrator; (b) Respondent(s)
shall designate one arbitrator; and (c) the respective arbitrators designated by
the Petitioner(s) and Respondent(s) shall select a third arbitrator within ten
Business Days following the date on which the last of them is designated;
provided, however, if the respective arbitrators designated by the Petitioner(s)
and Respondent(s) are unable to agree timely upon the selection of a third
arbitrator, the third arbitrator shall be appointed by the commercial panel of
the American Arbitration Association.
8.13.7 In the event a single arbitrator is used, the written decision
of that arbitrator shall be final and binding upon the Petitioner(s) and
Respondent(s). In the event three arbitrators are used, the written decision of
at least two of the three arbitrators shall be final and binding upon the
Petitioner(s) and Respondent(s).
8.13.8 With respect to any award in arbitration, the arbitrator(s):
(a) Shall issue an award in writing which (i) sets forth findings
of fact, (ii) resolves each specific Claim, (iii) attaches a reasoned opinion,
and (iv) is signed by the single arbitrator or by at least two of the three
arbitrators, as the case may be;
(b) Shall have no authority to award punitive damages;
(c) May not award money damages unless the notice identified in
Section 9.13.2 is delivered within two years after the right of action accrues
or, in the case of a counterclaim or cross-petition, within two years after the
delivery of such counterclaim or cross-petition, provided, however, for purposes
of computing this limitation period, all periods during which facts material to
the right of action are not known and reasonably could not be known by the
Petitioner(s) or Respondent(s) seeking money damages shall be excluded;
(d) May compel specific performance by the Petitioner(s) or the
Respondent(s) of their respective obligations under this Agreement or award
injunctive relief to
28
restrain any breach of this Agreement by a Petitioner or Respondent, in each
instance without the necessity of the Petitioner(s) (i) alleging or proving
damages as a result of the breach, or (ii) posting any bond; provided, however,
seeking or obtaining equitable relief shall not preclude a party to the
arbitration from also seeking or obtaining an award for money damages in the
arbitration subject to Sections 9.13.8(b) and 9.13.8(c);
(e) Shall adjust any award to assure that no Petitioner(s) or
Respondent(s) obtains double recovery for any amounts duplicative of amounts for
which such party, directly or indirectly, has already received credit (i) under
another adjustment mechanism set forth in this Agreement, or (ii) in the
calculation of the Final Closing Date Net Worth; and
(f) Shall assess to the non-prevailing party(ies) all (i)
administrative fees and expenses of the arbitrator(s) and the arbitration, and
(ii) fees and expenses incurred by the prevailing party(ies) in connection with
the arbitration; provided, however, the arbitrator(s) in its(their) discretion
may equitably allocate such fees and expenses between or among the Petitioner(s)
and Respondent(s).
8.13.9 Judgment upon an award in arbitration may be entered in any
court of competent jurisdiction in the United States.
8.14 RECITALS. Each recital to this Agreement is incorporated into and
shall constitute an integral part of this Agreement.
8.15 EXHIBITS AND DISCLOSURE SCHEDULE. Each Exhibit and the Disclosure
Schedule shall be incorporated into, and shall constitute an integral part of,
this Agreement by this reference thereto.
8.16 DISCLOSURE. At all times after the date of the shareholder approval
described in Section 4.1.8, UAHC shall comply in all material respects with the
applicable requirements of the Securities Act of 1933, as amended from time to
time, and the Securities and Exchange Act of 1934, as amended from time to time,
and the applicable rules and regulations of the SEC promulgated thereunder, with
respect to the disclosure of the existence of this Agreement, the Shareholder
Agreement (and the option granted to Buyer therein).
8.17 COUNTERPARTS. This Agreement may be executed in one or more
counterparts, each of which shall be deemed an original, and all of which
together shall constitute one and the same instrument.
[SIGNATURE PAGE IMMEDIATELY FOLLOWS]
29
[SIGNATURE PAGE TO PURCHASE AGREEMENT]
IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date
first above written.
THIS AGREEMENT CONTAINS A BINDING ARBITRATION PROVISION THAT MAY BE
ENFORCED BY THE PARTIES.
BUYER: THE COMPANY:
By: /s/ John C. Molina By: /s/ Stephen D. Harris
--------------------------------- -------------------------------------
Name: John C. Molina Name: Stephen D. Harris
Title: Chief Financial Officer Title: Chief Financial Officer
UAHC (OWNER): UTAT (OWNER):
By: /s/ William C. Brooks By: /s/ William C. Brooks
--------------------------------- ------------------------------------
Name: William C. Brooks Name: William C. Brooks
Title: Chairman and Chief Executive Title: Chairman and Chief Executive
Officer Officer
30
EXHIBIT A
DEFINITIONS
"AFFILIATE" means any Person who or which, directly or indirectly,
controls, is controlled by or is under common control with, the referenced
Person. For purposes of this definition, the term "control" (including
"controlled by" or "under common control with") includes the authority to (a)
approve the admission of a majority of the members, shareholders or partners of
the referenced Person, or (b) appoint, elect or approve a majority of the Board
of the referenced Person.
"AFFILIATE AGREEMENTS" means (i) the agreement executed by and among Buyer
(or an Affiliate of Buyer) and the Company regarding the administrative and
management services to be provided by Buyer to the Company, and (ii) the
agreement executed by and among Owner (or an Affiliate of Owner) and the Company
regarding the administrative and management services to be provided by Owner to
the Company. The form of such Affiliate Agreements is attached hereto as Exhibit
C, and the Affiliate Agreements shall be effective as of the Closing.
"AGREEMENT" has the meaning set forth in the preface to the purchase
agreement to which this Exhibit A is attached.
"AGREEMENT DATE" has the meaning set forth in the preface to the Agreement.
"AMENDED ARTICLES" means amendments to the articles of incorporation of the
Company as set forth in Section 3.4, and which are to become effective as of the
Closing.
"ARBITRATION RULES" means the Commercial Arbitration Rules of the American
Arbitration Association.
"BENEFIT PLAN" means (a) each health, dental, disability, life or other
insurance, (b) all supplemental unemployment benefits, and (c) each
profit-sharing, pension or retirement plan, program, agreement or arrangement,
in each instance, sponsored, maintained or contributed to or required to be
contributed to by the Company for the benefit of Employees, former employees of
the Company or employees of the Company on the Agreement Date who are not
Employees.
"BOARD" means the Board of Directors, Board of Managers, Board of Trustees
or similar governing body of the referenced Person.
"BUSINESS" means all of the operations conducted by the Company, including
arranging for the provision of comprehensive health care services pursuant to
the terms of the Medicaid Contract and Medicare Contract.
"BUSINESS DAY" means any day other than Saturday, Sunday or any day on
which banks in the City of New York, New York are closed.
"BUYER" has the meaning set forth in the preface to the Agreement.
1
"CLAIM" means any and all liabilities (whether asserted or unasserted,
absolute or contingent), obligations, losses, damages, deficiencies, demands,
disputes, claims, fines, penalties, interest, assessments, judgments, Liens,
charges, orders, decrees, rulings, dues, assessments, Taxes, actions,
injunctions, proceedings and suits of whatever kind and nature and all costs and
expenses relating thereto, including fees and expenses of counsel, accountants
and other experts, and other expenses of investigation and litigation.
"CLOSING" means consummation of the transaction whereby Buyer purchases the
Shares from Owner pursuant to the provisions of this Agreement.
"CLOSING DATE" means the date on which the Closing occurs.
"CMS" means the Centers for Medicare and Medicaid Services.
"CODE" means the Internal Revenue Code of 1986, as amended.
"THE COMPANY" has the meaning set forth in the preface to the Agreement.
"THE COMPANY ARTICLES" means the articles of incorporation in effect as of
the Agreement Date.
"CONFIDENTIAL INFORMATION" means, to the extent not generally available or
ascertainable from public or published information or trade sources or not a
part of the public domain, the following information related to the Company or
the Business: (a) financial statements, (b) rate, price, cost and expense data,
(c) trade secrets, (d) strategic planning information, (e) Enrollee information,
(f) agreements with providers and third party payors, (g) employee lists, (h)
vendor lists, and (i) all other information of a proprietary nature.
"CONFIDENTIALITY AGREEMENT" means that certain Mutual Confidentiality and
Non-Disclosure Agreement dated October 1, 2007, between Buyer and Owner.
"CONTRACT" means any contract, agreement, arrangement, understanding or
instrument, whether oral or written.
"DESIGNATED CONTRACTS" means those Contracts identified in Section 3.4.17
of the Disclosure Schedule.
"DISCLOSURE SCHEDULE" means the series of disclosures made by the Company
and/or Owner to Buyer on a document titled "Disclosure Schedule" and attached
hereto (or, in certain cases as identified in such attachment, by cd-rom).
"DOI" means the Tennessee Department of Commerce and Insurance.
"EMPLOYEE" means an employee of the Company on the Closing Date.
"EMPLOYMENT AGREEMENT" means a contract, offer letter or agreement of the
Company with any Employee, former employee of the Company or employee of the
Company on the Agreement Date who is not an Employee pursuant to which the
Company has any actual or
2
contingent liability or obligation to provide compensation or benefits in
consideration for past, present or future services (including payments in
connection with the transactions contemplated by this Agreement).
"ENROLLEES" means those individuals enrolled in the Medicaid and/or
Medicare managed care health plan established and maintained by the Company.
"ENVIRONMENTAL, HEALTH AND SAFETY REQUIREMENTS" means all Federal, state
and local statutes, laws, rules, regulations and ordinances concerning public
health and safety, worker health and safety, environmental regulation or control
and pollution or protection of the environment, including all those relating to
the presence, use, production, generation, handling, transportation, treatment,
storage, disposal, distribution, labeling, testing, processing, discharge,
release, threatened release, control or cleanup of any Hazardous Substances, as
such requirements are enacted and in effect on or prior to the Closing Date.
"ERISA" means the Employee Retirement Income Security Act of 1974, as
amended.
"FINANCIAL STATEMENTS" means the financial reports described in Section
2.4.11.
"FULL-RISK MEDICAID CONTRACT(S)" means one or more contracts to be executed
by the Company with the State Agency to provide comprehensive medical services
on a capitated, full-risk basis to Medicaid beneficiaries in either or both the
Western Grand Region of Tennessee or Eastern Grand Region of Tennessee.
"GAAP" means United States generally accepted accounting principles as in
effect from time to time, consistently applied.
"GOVERNMENTAL ENTITY" means any Federal, state, regional, county, municipal
or local court, agency, department, division, board, bureau or commission or
other governmental or regulatory authority.
"HAZARDOUS SUBSTANCE" means petroleum, petroleum by-products,
polychlorinated biphenyls and any other chemicals, materials, substances or
wastes which are currently defined or regulated as "hazardous substances,"
"hazardous materials," "hazardous wastes," "extremely hazardous wastes,"
"restricted hazardous wastes," "toxic substances," "toxic pollutants," "toxic
air pollutants," "hazardous air pollutants," "pollutants" or "contaminants"
under any Law.
"HIPAA" means the Health Insurance Portability and Accountability Act of
1996, as amended, and the rules and regulations promulgated thereunder.
"HSR ACT" means the Hart-Scott-Rodino Antitrust Improvements Act of 1976,
as amended, and the rules and regulations promulgated thereunder.
"IBNR" means the actuarial estimate of Medical Claims which remain unpaid,
including (a) undisputed Medical Claims reported to the Company, (b) Medical
Claims reported to the Company but disputed by the Company, and (c) Medical
Claims incurred but not yet reported to the Company.
3
"INDEMNITEE" means a Person entitled to indemnification pursuant to
Sections 6.1 or 6.2, as the case may be.
"INTELLECTUAL PROPERTY" means any United States or foreign trademarks,
trade names, service marks, Internet domain names, copyrights, inventions,
patents, trade secrets, know-how, proprietary processes, formulae, customer
lists, confidential information, computer software, databases, technology and
all other intellectual property rights, and any applications or registrations
relating to any of the foregoing and the goodwill relating to any of the
foregoing.
"KNOWLEDGE OF BUYER" means the actual knowledge of Buyer's Chief Executive
Officer, Chief Operating Officer or Chief Financial Officer after reasonable
inquiry of any employees of Buyer who have principal responsibility for the
matter in question or are otherwise likely to have information relevant to the
matter.
"KNOWLEDGE OF OWNER" means the actual knowledge of Owner's Chief Executive
Officer, Chief Operating Officer or Chief Financial Officer after reasonable
inquiry of any employees of Owner who have principal responsibility for the
matter in question or are otherwise likely to have information relevant to the
matter.
"LAWS" means all applicable Federal, state and local laws, policies, rules,
regulations, orders, guidance, interpretations, manuals and communications,
including Medicaid, Medicare, the State HMO Law, HIPAA, the Environmental,
Health and Safety Requirements and the Securities Act.
"LEASES" means all leases and other agreements (written or oral), including
all amendments, extensions, renewals, guarantees and other agreements with
respect thereto in which the Company is the lessee or lessor.
"LICENSE" means any franchise, approval, permit, order, authorization,
consent, license, registration or filing, certificate, variance and any other
similar right obtained from or filed with any Governmental Entity.
"LIEN" means any mortgage, pledge, lien, charge, security interest, defect
of title, encroachment, adverse claim of ownership or use, deficiency,
exception, restriction on transfer (such as a right of first refusal) or other
encumbrance of any kind or character.
"MATERIAL ADVERSE EFFECT" means any event, occurrence, circumstance, change
or other matter which, individually or in the aggregate with any other events,
occurrences, circumstances, changes or other matters, has, or is reasonably
likely to have, (a) an adverse monetary effect on the Business or the prospects
of the Business exceeding $1,000,000 during the period commencing on the
Agreement Date and ending on the Closing Date, exclusive of Medical Claims, or
(b) an adverse effect on the ability of any Party to consummate the transactions
contemplated by this Agreement.
"MEDICAID" means the Federal-State health insurance programs administered
by the State through the State Agency which provide medical assistance to
eligible persons covered under Title XIX and Title XXI (including the State
Children's Health Insurance Program) of the Social Security Act.
4
"MEDICAID CONTRACT" means the agreement between the State Agency and the
Company, as amended from time to time, pursuant to which the Company provides
administrative services to the State Agency.
"MEDICAL CLAIMS" means all medical claims, liabilities or other obligations
incurred by the Company on or prior to the Closing Date in connection with the
provision of covered health care services to Enrollees.
"MEDICARE" means the Federal health insurance program administered by CMS
as Medicare Advantage and that provides medical assistance to eligible persons.
"MEDICARE CONTRACT" means the contract between the Company and CMS
effective as of January 1, 2008, and as amended from time to time, pursuant to
which the Company provides comprehensive health care services to Medicare
Enrollees.
"MINIMUM NET WORTH" means Fifteen Million Dollars ($15,000,000) in
statutory net worth as determined in accordance with SAP (provided, however, for
purposes of this Agreement, no credit shall be given to any sums attributed to
deferred tax assets or goodwill), and such determination shall be subject to
post-close adjustments made within six months following the Closing Date that
reconcile accrued amounts at the close with actual amounts.
"NOTICE OF CLAIM" has the meaning set forth in Section 6.3.
"ORDINARY COURSE OF BUSINESS" means the conduct of the Business in a
commercially reasonable manner in the ordinary course consistent with past
practices and in compliance in all material respects with applicable Laws and
contractual obligations.
"OWNER" has the meaning set forth in the preface to the Agreement.
"PARTY" or "PARTIES" has the meaning set forth in the preface to the
Agreement.
"PERMITTED LIENS" means (a) liens for current Taxes not yet due and payable
or for current Taxes which the taxpayer is contesting in good faith through
appropriate proceedings and for which appropriate reserves have been established
in accordance with GAAP, (b) purchase money liens and liens securing rental
payments under capital lease arrangements, arising in each case in the Ordinary
Course of Business, that would not, individually or in the aggregate, materially
interfere with the present use of or materially impair the value of the affected
assets or properties, (c) liens of landlords, mechanics, materialmen, workmen,
repairmen, warehousemen and carriers arising in the Ordinary Course of Business
which are not overdue and which would not, individually or in the aggregate,
materially interfere with the present use of or materially impair the value of
the affected assets or properties, and (d) all applicable zoning, building and
similar laws which are not violated by current occupancy or use and which would
not, individually or in the aggregate, materially interfere with the present use
of or materially impair the value of the affected assets or properties.
"PERSON" means an individual, partnership, corporation, limited liability
company, an unincorporated association, joint stock company, trust, joint
venture and any other entity, including a Governmental Entity.
5
"PETITIONER" means a Party or an Indemnitee asserting a Claim in
arbitration pursuant to Section 8.13.
"PRE-CLOSING LIABILITIES" means liabilities or obligations, direct or
indirect, absolute or contingent, known or unknown, whether or not accrued,
arising from or related to the operations of the Business prior to the Closing
Date other than liabilities or obligations (a) accrued or reserved for on the
balance sheets included in the Financial Statements, or (b) set forth in the
Disclosure Schedule.
"PROVIDER" means any physician, hospital, skilled nursing facility, home
health agency or other Person or network of Persons who or which is engaged in
providing or arranging for the provision of health care or related services or
supplies to or for the benefit of the Company.
"PROVIDER AGREEMENTS" means Contracts entered into with Providers by the
Company for the provision of health care or related services or supplies to
Enrollees.
"PURCHASE PRICE" means a sum equal to (i) $4,500,000 in the event the
Company executes one (1) Full-Risk Medicaid Contract, or (ii) $18,040,000 in the
event the Company executes two (2) Full-Risk Medicaid Contracts.
"REPRESENTATIVE" means, with respect to any Person, any manager, director,
officer, employee, lender, partner or agent, including any accountant,
consultant, banker, attorney or financial advisor, of such Person.
"RESPONDENT" means a Party or Indemnitee against whom or which a Claim is
asserted by a Petitioner or Petitioners.
"SAP" means statutory accounting principles as codified by the National
Association of Insurance Commissioners subject to the exceptions mandated by the
DOI.
"SECURITIES ACT" means the Securities Act of 1933, as amended, and the
rules and regulations promulgated thereunder.
"SHARES" means the issued and outstanding shares to be issued by the
Company to Buyer and that represent the percentage interest set forth in Section
2.4.9(a).
"SHAREHOLDER AGREEMENT" means the agreement executed by and among Buyer,
Owner, and the Company to be effective as of the Closing regarding the rights
and obligations of the parties as shareholders in the Company. The form of such
Shareholder Agreement is attached hereto as Exhibit D, and the Shareholder
Agreement shall be effective as of the Closing.
"STATE" means the State of Tennessee.
"STATE AGENCY" means the State Department of Finance and Administration,
Bureau of TennCare.
"STATE HMO LAW" means the Tennessee statutes and regulations regulating
health maintenance organizations, as amended from time to time.
6
"TAX ALLOCATION AGREEMENT" means the agreement executed by Owner and
certain of its subsidiaries, including the Company, governing the allocation of
Federal income taxes among Owner (as the parent) and its current and future
subsidiaries that are required under the Code to file consolidated income tax
returns.
"TAX CLAIM" means any pending or threatened audit or assessment, suit,
proposed adjustment, deficiency, dispute, administrative or judicial proceeding
or other similar claim by a taxing authority related to Taxes.
"TAXES" means (a) all net income, gross income, gross receipts, sales, use,
ad valorem, franchise, profits, license, lease, service, service use,
withholding, employment, payroll, earnings, net worth, unemployment insurance,
Social Security, Medicare, excise, severance, transfer, value added,
documentary, mortgage, registration, stamp, occupation, real or personal
property, environmental, premium, property, windfall profits, customs, duties
and other taxes, fees, levies, assessments or charges of any kind whatsoever,
together with any interest, penalties, fines and other additions with respect
thereto, imposed by any Federal, state or local government, (b) any penalties,
interest, fines or other additions to tax for the failure to collect, withhold,
file or pay over any of the foregoing, or to file any Tax Return which is
untrue, incorrect or incomplete, and (c) amounts which could become payable, in
whole or in part, by a person liable with respect to the items identified in
subparagraphs (a) and (b) immediately above (including any obligation in
connection with (i) a duty to collect, withhold or pay over any Tax, (ii) any
obligation to contribute to the payment of any Taxes determined on a
consolidated, combined or unitary basis, (iii) any liability as a transferee, or
(iv) any liability as a result of any express or implied obligation to indemnify
or pay the Tax obligations of another person). "Tax" means any one of the
foregoing Taxes.
"TAX RETURNS" means (a) all reports, declarations, filings, questionnaires,
estimates, returns, information statements and similar documents relating to, or
required to be filed in respect of, any Taxes, including any amendments thereof,
and (b) any statements, returns, reports or similar documents required to be
filed pursuant to Part III of Subchapter A of Chapter 61 of the Code or pursuant
to any similar income, excise or other tax provision of Federal, state or local
law, including any amendments thereof. "Tax Return" means any one of the
foregoing Tax Returns.
"TERRITORY" means the State of Tennessee.
"THIRD PARTY" means any Person other than a Party or an Affiliate of a
Party.
"TRANSFER TAXES" means any sales, use, transfer, stamp, registration,
documentary, recording or similar Taxes, if any, together with any interest,
penalties, fines, costs, fees, additions to tax or additional amounts with
respect thereto, incurred in connection with the transactions contemplated by
this Agreement.
7
EXHIBIT B
NOTICES
IF TO THE COMPANY: UAHC HEALTH PLAN
ATTN: PRESIDENT
1769 PARAGON DRIVE, SUITE 100
MEMPHIS, TN 38132
IF TO OWNER: UNITED AMERICAN OF TENNESSEE, INC.
ATTN: CHIEF FINANCIAL OFFICER
300 RIVER PLACE, SUITE 4950
DETROIT, MI 48207
WITH A COPY TO: HONIGMAN MILLER SCHWARTZ AND COHN LLP
ATTN: ALEX L. PARRISH
2290 FIRST NATIONAL BUILDING
DETROIT, MI 48226
IF TO BUYER: MOLINA HEALTHCARE, INC.
ATTN: CHIEF FINANCIAL OFFICER
200 OCEANGATE, SUITE 100
LONG BEACH, CA 90802-4317
WITH A COPY TO: MOLINA HEALTHCARE, INC.
LEGAL AFFAIRS DEPARTMENT
ATTN: CHIEF LEGAL OFFICER
2277 FAIR OAKS BOULEVARD, SUITE 440
SACRAMENTO, CA 95825
IF TO UAHC: UNITED AMERICAN HEALTHCARE CORPORATION
ATTN: CHIEF FINANCIAL OFFICER
300 RIVER PLACE, SUITE 4950
DETROIT, MI 48207
WITH A COPY TO: HONIGMAN MILLER SCHWARTZ AND COHN LLP
ATTN: ALEX L. PARRISH
2290 FIRST NATIONAL BUILDING
DETROIT, MI 48226
EXHIBIT C
AFFILIATE AGREEMENTS
(Omitted from APPENDIX A to Proxy Statement of
United American Healthcare Corporation
dated ________, 2008, because not material)
2
EXHIBIT D
SHAREHOLDER AGREEMENT
3
EXHIBIT D
SHAREHOLDER AGREEMENT
UAHC HEALTH PLAN OF TENNESSEE, INC.
SHAREHOLDER AGREEMENT
This Shareholder Agreement (this "Agreement") is dated as of _________,
2008, and is executed on the dates set opposite the signatures below by and
among the persons who own (or will own once they are issued) all of the Shares
(as defined below) (each a "Shareholder," collectively the "Shareholders") and
UAHC Health Plan of Tennessee, Inc., a Tennessee corporation (the
"Corporation").
RECITALS
A. Pursuant to that certain Purchase Agreement dated as of March 24, 2008
("Purchase Agreement"), Molina Healthcare, Inc., a Delaware corporation ("MHI")
has agreed to acquire _________ shares of capital stock of the Corporation from
United American of Tennessee, Inc., a Tennessee corporation ("UAHC"), upon the
condition, among others, that the Shareholders and the Corporation enter in this
Agreement.
B. Upon the closing of the purchase agreement described above, the
Shareholders will own all of the issued and outstanding shares of capital stock
of the Corporation (the "Shares").
C. In order to facilitate the management of the Corporation, the
implementation of any administrative services agreements among the Shareholders
and the Corporation, and the ability of the Corporation to effectively govern
its affairs, the Shareholders and the Corporation desire to enter into this
Agreement.
AGREEMENT
ARTICLE 1
GENERAL PROVISIONS
1.1 RESTRICTION ON TRANSFER. To accomplish the purpose of this Agreement,
any transfer, conveyance, sale, gift, assignment, pledge, mortgage,
hypothecation, encumbrance, exchange, or alienation of any of the Shares,
whether voluntary, involuntary or by operation of law (in each event a
"Transfer"), other than according to the terms of this Agreement is void and
transfers no right, title or interest in or to any of these shares to the
purported transferee, buyer, donee, assignee, pledgee, or encumbrance holder.
This Agreement is made with respect to all of
1
the Shares, whether outstanding now or at any later date. Each Shareholder shall
have the right to vote Shares owned of record in such Shareholder's name and to
receive dividends payable on such Shares until such Shares are sold or
transferred as provided in this Agreement.
1.2 AGREEMENT AVAILABLE FOR INSPECTION. An original of this Agreement, duly
executed by the Corporation and each of the Shareholders, shall be delivered to
the Secretary of the Corporation, maintained by the Secretary at the principal
executive office of the Corporation, and made available for inspection by any
person requesting to see it.
1.3 LEGEND ON SHARE CERTIFICATE. Each Shareholder agrees that the
certificates representing Shares (and any certificates issued pursuant to
Section 3.3) shall display the following legend in a prominent manner:
Notice is hereby given that the transfer, sale, assignment, hypothecation,
encumbrance, or alienation of the shares represented by this certificate is
restricted by a Shareholder Agreement among this Corporation and all the
Shareholders of this Corporation.
A copy of such agreement is available for inspection during normal business
hours at the principal executive office of the Corporation. All the terms
and provisions of such agreement are hereby incorporated by reference and
made a part of this certificate.
The shares represented by this certificate have been acquired for
investment and have not been registered under the Securities Act of 1933,
as amended. The shares represented by this certificate have been issued
pursuant to an exemption from qualification under the Tennessee Securities
Law, as amended.
ARTICLE 2
OWNERSHIP, VESTING AND PURCHASE OF SHARES
2.1 OWNERSHIP OF SHARES. After Closing, as defined in the Purchase
Agreement, the Shareholders will own all of the Shares as follows:
MHI - ______ shares
UAHC - _____ shares
2.2 RIGHT OF FIRST REFUSAL. Except as provided in this Agreement, each of
the Shareholders agrees not to Transfer any Shares by any means without offering
to Transfer such Shares to the other Shareholder as set forth in this Section.
(a) Pursuant to the terms and conditions set forth in this Section,
each of the Shareholders (the "Selling Shareholder") hereby grants to the other
Shareholder (the "Acquiring Shareholder), and such Acquiring Shareholder hereby
accepts from the Selling Shareholder, a right of first refusal, as more
specifically set forth in this Section. In the event a Selling Shareholder
receives a bona fide written offer, whether or not solicited, from any
unaffiliated
2
third party, as defined below (the "Third-Party Offer") to purchase any Shares,
and if such Selling Shareholder is willing to accept such offer, then such
Selling Shareholder shall deliver a copy of the Third Party Offer to the
Acquiring Shareholder accompanied by copies of all information previously
delivered to said third-party, along with such Selling Shareholder's written
offer to sell the Shares to the Acquiring Shareholder upon the same terms and
conditions as set forth in such Third-Party Offer (the "Selling Shareholder's
Offer").
(b) The Acquiring Shareholder shall have the option, exercisable
within fifteen (15) days after receipt of the Selling Shareholder's Offer, to
purchase all of the Shares that are the subject of the Selling Shareholder's
Offer upon the terms and conditions set forth in the Selling Shareholder's
Offer.
(i) If the Selling Shareholder's Offer includes non-cash
consideration (including, but not limited to, promissory note, marketable or
unmarketable securities, or real estate) the Acquiring Shareholder shall propose
similar non-cash consideration, which such Selling Shareholder, at its sole
option, may accept or reject. In the event the Selling Shareholder rejects the
Acquiring Shareholder's proposal of non-cash consideration, the non-cash
consideration set forth in the Selling Shareholder's Offer shall be valued, as
set forth below, and such valuation shall be paid to such Selling Shareholder in
cash in accordance with the other terms and conditions set forth in the Selling
Shareholder's Offer.
(ii) If the Acquiring Shareholder and the Selling Shareholder are
unable to reach agreement through negotiations between themselves within fifteen
(15) days after such Selling Shareholder's written rejection of the Acquiring
Shareholder's proposed non-cash consideration, the value of the non-cash
consideration shall be determined by an independent appraiser in the following
manner:
(A) Within ten (10) business days, each party shall engage
at their sole expense one (1) appraiser with experience in the health care
industry, and such appraisers shall select a third appraiser with experience in
the health care industry, who shall be engaged as the sole appraiser to
determine the value of the non-cash consideration;
(B) Any value of the non-cash consideration determined in
accordance herewith shall, in the absence of fraud or gross negligence, be
binding and conclusive upon the Acquiring Shareholder and the Selling
Shareholder; and
(C) The costs, expenses, and fees of such appraiser shall be
paid one-half (1/2) by the Acquiring Shareholder and the Selling Shareholder.
(c) For purposes of this Agreement, "unaffiliated third party" means
any individual, person, corporation, partnership or other entity (i) of which
any Selling Shareholder, or an immediate family member of any Selling
Shareholder has thirty-three percent (33%) or less ownership or control, (ii)
which is not under common ownership or control with any Selling Shareholder, an
immediate family member of any Selling Shareholder (where control means
thirty-three percent (33%) or greater voting representation of partners,
shareholders, board of directors or other governing body), and (iii) who is not
an immediate family member of any Selling Shareholder.
3
(d) If the Acquiring Shareholder fails to timely exercise its right of
first refusal granted herein, then the Shares may be Transferred to the proposed
transferee on the same terms and conditions set forth in the Third Party Offer
for up to sixty (60) days, after which the provisions of this Section must again
be complied with before any Transfer.
(e) Notwithstanding that the Shares are transferred to a third-party
in accordance with this Agreement, the right of first refusal granted to the
Acquiring Shareholder shall continue to apply to all Shares and to any
subsequent Transfer.
2.3 TAG-ALONG RIGHTS.
(a) In the event of a proposed Transfer of Shares by a Shareholder (a
"Transferring Shareholder"), each Shareholder (other than the Transferring
Shareholder) shall have the right to participate on the same terms and
conditions and for the same per Share consideration as the Transferring
Shareholder in the Transfer in the manner set forth in this Section 2.3. Prior
to any such Transfer, following compliance with Section 2.2, the Transferring
Shareholder shall deliver to the Corporation prompt written notice (the
"Transfer Notice"), which the Corporation will forward to the Shareholders
(other than the Transferring Shareholder, the "Tag-Along Participants") within 5
days of receipt thereof, which notice shall state (i) the name of the proposed
Transferee, (ii) the number of Shares proposed to be Transferred (the
"Transferred Securities") and the percentage (the "Tag Percentage") that such
number of Shares constitute of the total number of Shares owned by such
Transferring Shareholder, (iii) the proposed purchase price, including a
description of any non-cash consideration sufficiently detailed to permit the
determination of the fair market value thereof, and (iv) the other material
terms and conditions of the proposed Transfer, including the proposed Transfer
date (which date may not be less than 35 days after delivery to the Tag-Along
Participants of the Transfer Notice). Such notice shall be accompanied by a
written offer from the proposed Transferee to purchase the Transferred
Securities, which offer may be conditioned upon the consummation of the sale by
the Transferring Shareholder, or the most recent drafts of the purchase and sale
documentation between the Transferring Shareholder and the Transferee which
shall make provision for the participation of the Tag-Along Participants in such
sale consistent with this Section 2.3.
(b) Each Tag-Along Participant may elect to participate in the
proposed Transfer to the proposed Transferee identified in the Transfer Notice
by giving written notice to the Corporation and to the Transferring Shareholder
within the 15 day period after the delivery of the Transfer Notice to such
Tag-Along Participant, which notice shall state that such Tag-Along Participant
elects to exercise its rights of tag-along under this Section 2.3 and shall
state the maximum number of shares sought to be Transferred (which number may
not exceed the product of (i) all such Shares owned by such Tag-Along
Participant, multiplied by (ii) the Tag Percentage). Each Tag-Along Participant
shall be deemed to have waived its right of tag-along with respect to the
Transferred Securities hereunder if it fails to give notice within the
prescribed time period. The proposed Transferee of Transferred Securities will
not be obligated to purchase a number of Shares exceeding that set forth in the
Transfer Notice, and in the event such Transferee elects to purchase less than
all of the additional Shares sought to be Transferred by the Tag-Along
Participants, the number of Shares to be Transferred by the Transferring
Shareholder and each such Tag-Along Participant shall be reduced so that each
such Shareholder
4
is entitled to sell its Pro Rata Portion of the number of Shares the proposed
Transferee elects to purchase (which in no event may be less than the number of
Transferred Securities set forth in the Transfer Notice).
(c) Each Tag-Along Participant, if it is exercising its tag-along
rights hereunder, shall deliver to the Transferring Shareholder at the closing
of the Transfer of the Transferring Shareholder's Transferred Securities to the
Transferee certificates representing the Transferred Securities to be
Transferred by such holder, duly endorsed for transfer or accompanied by stock
powers duly executed, in either case executed in blank or in favor of the
applicable purchaser against payment of the aggregate purchase price therefor by
wire transfer of immediately available funds. Each Shareholder participating in
a sale pursuant to this Section 2.3 shall receive consideration in the same form
and per share amount after deduction of such Shareholder's proportionate share
of the related expenses. Each Shareholder participating in a sale pursuant to
this Section 2.3 shall agree to make or agree to the same customary
representations, covenants, indemnities and agreements as the Transferring
Shareholder so long as they are made severally and not jointly and the
liabilities thereunder are borne on a pro rata basis based on the consideration
to be received by each Shareholder; provided, that any general indemnity given
by the Transferring Shareholder, applicable to liabilities not specific to the
Transferring Shareholder, to the Transferee in connection with such sale shall
be apportioned among the Shareholders participating in a sale pursuant to this
Section 2.3 according to the consideration received by each such Shareholder and
shall not exceed such Shareholder's net proceeds from the sale; provided,
further, that any representation relating specifically to a Shareholder and/or
its ownership of the Equity Securities to be Transferred shall be made only by
that Shareholder. The fees and expenses incurred in connection with a sale under
this Section 2.3 and for the benefit of all Shareholders (it being understood
that costs incurred by or on behalf of a Shareholder for his, her or its sole
benefit will not be considered to be for the benefit of all Shareholders), to
the extent not paid or reimbursed by the Corporation or the Transferee or
acquiring Person, shall be shared by all the Shareholders on a pro rata basis,
based on the consideration received by each Shareholder in respect of its Equity
Securities to be Transferred; provided that no Shareholder shall be obligated to
make any out-of-pocket expenditure prior to the consummation of the transaction
consummated pursuant to this Section 2.3 (excluding de minimis expenditures).
The proposed Transfer date may be extended beyond the date described in the
Transfer Notice to the extent necessary to obtain required approvals of
Governmental Entities and other required approvals and the Corporation and the
Shareholders shall use their respective commercially reasonable efforts to
obtain such approvals.
(d) If the Transferring Shareholder sells or otherwise Transfers to
the Transferee any of its Shares in breach of this Section 2.3, then each
Tag-Along Participant shall have the right to sell to each Transferring
Shareholder, and each Transferring Shareholder undertakes to purchase from each
Tag-Along Participant, the number of Shares that such Tag-Along Participant
would have had the right to sell to the Transferee pursuant to this Section 2.3,
for a per Share amount and form of consideration and upon the terms and
conditions on which the Transferee bought such Shares from the Transferring
Shareholder, but without any indemnity being granted by any Tag-Along
Participant to the Transferring Shareholder; provided that nothing contained in
this Section 2.3(d) shall preclude any Shareholder from seeking alternative
remedies against any such Transferring Shareholder as a result of its breach of
this Section 2.3.
5
ARTICLE 3
ADDITIONAL SHARES
3.1 ADDITIONAL CAPITAL INVESTMENT; DIVIDENDS. A Shareholder will be issued
additional Shares by the Corporation whenever, upon a capital call issued by the
Board of Directors of the corporation as set forth below, such Shareholder makes
an additional investment in the Corporation either (a) to provide working
capital reasonably required by the Corporation for its operations, or (b) to
provide capital for acquisitions of equipment or other capital expenditures, (c)
as may be required by the State Agency or DOI, or (d) for other business
purposes as may be reasonably determined by the Corporation for its operations.
Such Shareholder shall be issued the number of Shares as the Board of Directors
and the contributing Shareholder shall agree upon at such time. Nothing herein
shall be construed as requiring or mandating any additional investment by any
Shareholder in the Corporation.
ARTICLE 4
OPTION
4.1 GRANT OF OPTION TO MHI.
(a) Pursuant to the terms and conditions set forth herein, UAHC grants
to MHI, and MHI accepts from UAHC, the exclusive right and option (the "Option")
to purchase all of UAHC's right, title and interest in and to the stock of the
Corporation then owned by UAHC ("UAHC Stock"). The Option may be exercised at
any time between the dates that are twenty-four (24) months and forty-eight (48)
months (in the event the Corporation executes one (1) Full-Risk Medicaid
Contract), or thirty-six (36) months and sixty (60) months (in the event the
Corporation executes two (2) Full-Risk Medicaid Contracts), from the effective
date of the Full-Risk Medicaid Contract(s) (as described in the Purchase
Agreement). Further, in the event the Corporation executes one (1) Full-Risk
Medicaid Contract, the Option may be exercised at any time (i) the Corporation
requires a capital infusion of more than $5,000,000 upon a capital call by the
Board of Directors as set forth above, or the Corporation requires additional
capital as mandated by the State Agency and/or DOI, and (ii) UAHC declines for
whatever reason to contribute its proportionate share, and (iii) MHI elects to,
and actually contributes one hundred percent (100%) of the required capital.
(b) The purchase price for the UAHC Stock shall be equal to the then
percentage interest UAHC owns of the Corporation multiplied by the Fair Market
Value of the Corporation, as defined herein;
(c) The "Fair Market Value of the Corporation" shall be measured as of
the closing date of the purchase as set forth above, and shall be equal to the
sum of (1) the Medicaid membership multiplied by $345 per Medicaid member), plus
(2) the Medicare Advantage and/or Medicare Advantage Special Needs Plan
membership multiplied by $2,500 per Medicare member, plus (3) the market value
of any Medicare Advantage Prescription Drug Program ("PDP") plan business
operations, plus (4) the then sum of capital held by the Corporation in excess
of the statutory minimum capital required. For purposes of establishing the
market value
6
of the Medicare Advantage PDP line of business, the parties will agree upon a
dispute resolution process in the event the parties cannot reach agreement as to
the value of such line of business.
(d) The Option shall be exercised by MHI giving a written notice of
exercise, and preparing and delivering a stock purchase agreement ("UAHC Stock
Purchase Agreement") to UAHC. Such UAHC Stock Purchase Agreement shall be in
form and substance similar to the Purchase Agreement; provided, however, such
UAHC Stock Purchase Agreement shall include provisions for indemnification,
non-competition, and non-solicitation that are usual and customary for similar
transactions in which a majority owner is conveying its stock holdings.
(e) If MHI gives UAHC a timely Notice of Exercise and UAHC Stock
Purchase Agreement, UAHC shall (i) execute and deliver the UAHC Stock Purchase
Agreement to MHI within fifteen (15) days of delivery of the MHI's notice of
exercise, and (ii) pursuant to the UAHC Stock Purchase Agreement, close the
purchase and sale of the UAHC Stock within three (3) days thereafter by delivery
of the UAHC Stock to MHI properly endorsed, and accompanied by any other
instruments necessary to transfer the UAHC Stock to MHI.
(f) To the extent not previously conveyed, UAHC shall arrange for its
tangible and intangible assets, and the tangible and intangible assets of its
Affiliates, that are used and useful to the business of the Corporation to be
transferred and conveyed to the Corporation prior to the closing at not cost or
charge. In addition, UAHC shall grant the Corporation a royalty-free license in
perpetuity for Healthtrek for use in Tennessee. Such assets shall include
network contracts, vendor contracts, and software licenses; provided, however,
that such assets shall not include the assets set forth in Exhibit A, attached
hereto. In addition, MHI shall have the right to offer employment at the
Corporation to any employees of UAHC or its Affiliates who primarily worked on
the business and operations of the Corporation, and UAHC shall reasonably
cooperate in conveying such offers of employment to such employees.
(g) All closing costs, including, but not limited to the attorney's
fees of each party, shall be borne solely by the party incurring such costs or
fees.
(h) Further, in the event the shareholder approval described in
Section 4.1.8 of the Purchase Agreement is not obtained for any reason (and such
condition to closing is waived by Buyer), the option to acquire the remaining
Shares by Buyer set forth herein shall be amended so that Buyer shall have an
option to only acquire the maximum number of Shares that will permit UAHC to
retain a significant continuing business activity as set forth under state and
federal statutes and regulations, and therefore the Purchase Agreement shall
not, and the transactions (including the grant of option to MHI) set forth
herein shall not, require shareholder approval.
4.2 GRANT OF OPTION TO UAHC.
(a) Pursuant to the terms and conditions set forth herein, MHI grants
to UAHC, and UAHC accepts from MHI, the exclusive right and option (the
"Option") to purchase all of MHI's right, title and interest in and to the stock
of the Corporation then owned by MHI ("MHI Stock"). The Option may be exercised
at any time between the dates that are sixty (60)
7
months and seventy-two (72) months from the effective date of the full-risk
Medicaid Contract (as described in the Purchase Agreement).
(b) The purchase price for the MHI Stock shall be equal to the then
percentage interest MHI owns of the Corporation multiplied by the Fair Market
Value of the Corporation.
(c) The Option shall be exercised by UAHC giving a written notice of
exercise, and preparing and delivering a stock purchase agreement ("MHI Stock
Purchase Agreement"), to MHI. Such MHI Stock Purchase Agreement shall be in form
and substance similar to the Purchase Agreement; provided, however, such MHI
Stock Purchase Agreement shall include provisions for indemnification,
non-competition, non-solicitation, and true-ups for changes in net worth, IBNR,
and working capital that are usual and customary for similar transactions in
which a minority owner is conveying its stock holdings.
(d) If UAHC gives MHI a timely Notice of Exercise and MHI Stock
Purchase Agreement, MHI shall (i) execute and deliver the MHI Stock Purchase
Agreement to UAHC within fifteen (15) days of delivery of UAHC's notice of
exercise, and (ii) pursuant to the MHI Stock Purchase Agreement, close the
purchase and sale of the MHI Stock within three (3) days thereafter by delivery
of the MHI Stock to UAHC properly endorsed, and accompanied by any other
instruments necessary to transfer the MHI Stock to UAHC.
(e) All closing costs, including, but not limited to the attorney's
fees of each party, shall be borne solely by the party incurring such costs or
fees.
4.3 GRANT OF PUT TO MHI.
(a) Pursuant to the terms and conditions set forth herein, UAHC grants
to MHI, and MHI accepts from UAHC, the exclusive right and option to require
UAHC to purchase all of the MHI Stock ("Put"). The Put may be exercised at any
time between the dates that are sixty (60) months and seventy-two (72) months
from the effective date of the full-risk Medicaid Contract (as described in the
Purchase Agreement).
(b) The purchase price for the MHI Stock shall be equal to the then
percentage interest MHI owns of the Corporation multiplied by the Total Value of
the Corporation as set forth below.
(c) The Put shall be exercised by MHI giving a written notice of
exercise, and preparing and delivering the MHI Stock Purchase Agreement to UAHC,
along with the proposed valuation of the Corporation (the "Total Value of the
Corporation"). Such MHI Stock Purchase Agreement shall be in form and substance
similar to the Purchase Agreement; provided, however, such MHI Stock Purchase
Agreement shall include provisions for indemnification, non-competition, and
non-solicitation that are usual and customary for similar transactions in which
a minority owner is conveying its stock holdings.
(d) If MHI delivers to UAHC a timely Notice of Exercise and MHI Stock
Purchase Agreement, UAHC shall execute and deliver the MHI Stock Purchase
Agreement to MHI within fifteen (15) days of delivery of MHI's notice of
exercise. At such time, UAHC shall
8
either agree to the Total Value of the Corporation proposed by MHI or shall
propose an alternative Total Value of the Corporation. If the parties cannot
agree upon the Total Value of the Corporation within thirty (30) days of the
date of the Notice of Exercise, the parties shall arbitrate the Total Value of
the Corporation in accordance with the arbitration procedures set forth in the
Purchase Agreement.
(e) Pursuant to, and in accordance with, the MHI Stock Purchase
Agreement, the parties shall close the purchase and sale of the MHI Stock by
delivery of the purchase price as soon as possible, but in no event more than
ninety (90) days after the date of the Notice of Exercise. Concurrently
therewith, MHI shall deliver to UAHC the MHI Stock properly endorsed, and
accompanied by any other instruments necessary to transfer the MHI Stock to
UAHC.
(f) All closing costs, including, but not limited to the attorney's
fees of each party, shall be borne solely by the party incurring such costs or
fees.
ARTICLE 5
MISCELLANEOUS PROVISIONS
5.1 OBLIGATIONS OF TRANSFEREES. Unless otherwise expressly provided by this
Agreement, each transferee and each subsequent transferee of Shares, or any
interest in Shares, shall hold the Shares or interest therein subject to all of
the provisions of this Agreement. Any such transferee shall make no further
transfers except as permitted by this Agreement.
5.2 NECESSARY ACTS. All parties to the Agreement, the Corporation and all
of the Shareholders, shall perform any and all acts as well as execute any and
all documents that may be reasonably necessary to fully carry out the provisions
and intent of this Agreement.
5.3 FULL ACCESS. During the period that this Agreement is in effect, the
Shareholders and the Corporation shall permit Representatives of the
Shareholders to have full access at all reasonable times, and in a manner so as
not to interfere with the normal business operations of the Corporation, to all
premises, properties, personnel, books, records, Tax Returns, Contracts and
documents of or pertaining to the Corporation and its businesses, and the
Corporation shall permit Representatives of MHI to attend as non-participating
observers all Corporation board of directors meetings. In the event MHI's
percentage ownership interest in the Corporation shall increase to twenty-five
percent or more, the parties shall agree to reasonably amend this Agreement to
include the governance provisions set forth in Exhibit "1" attached hereto.
5.4 NOTICES. Any or all notices, demands, requests or other communications
required or permitted by this Agreement or by law to be served on, given to, or
delivered to any party hereto by any other party to this Agreement shall be in
writing and shall be deemed duly served, given, or delivered when personally
delivered to the party or to an officer of the party, or in lieu of such
personal delivery, when deposited in the United States mail, first class postage
prepaid, addressed to the Corporation at the address of its principal office,
___________________________________, or to a Shareholder at the address then
appearing for him or her on the books and records of the Corporation; provided,
however, any requirement in
9
this Agreement that an act be done by the Secretary of the Corporation within a
specified time after receipt of any notice or other communication means the act
must be done within the specified time after the notice or other communication
has actually arrived at the office of the Corporation. The Corporation may
change the address of its principal office in the manner required by law for
purposes of this section by giving notice of the change, in the manner required
by this section, to each of the Shareholders.
5.5 BINDING ON HEIRS. This Agreement shall be binding on the parties hereto
and on each of their heirs, executors, administrators, successors and assigns.
5.6 SEVERABILITY. It is the intent of the parties hereto that this
Agreement shall comply with and be governed by the provisions of all applicable
state and federal statutes and regulations. To the extent that it may be
determined that any of the provisions hereof are inconsistent with the
provisions of such statutes and regulations, the parties hereto agree that such
provisions of law shall be controlling and that the parties hereto will be bound
by the provisions of such statutes and regulations as though the provisions
thereof were contained herein. Should any provision or portion of this Agreement
be held unenforceable or invalid for any reason, the remaining provisions and
portions of this Agreement shall be unaffected by such holding.
5.7 ENTIRE AGREEMENT; AMENDMENT. This Agreement sets forth the entire
agreement between the Shareholders and the Corporation regarding, and supersedes
all prior negotiations and agreements, written or oral, concerning or relating
to, the subject matter of this Agreement, and this Agreement may not be modified
except by a writing executed by all parties in accordance with the terms of this
Agreement.
5.8 COUNTERPARTS. This Agreement may be executed in several counterparts,
each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument.
5.9 ATTORNEYS' FEES. If any party to this Agreement brings any arbitration
or action at law or in equity to enforce or interpret the terms of this
Agreement or for an alleged breach of this Agreement, the prevailing party or
parties shall be entitled to recover from the losing party or parties,
reasonable attorneys' fees in addition to other relief to which such party or
parties may be entitled.
[SIGNATURE PAGE IMMEDIATELY FOLLOWS]
10
[SIGNATURE PAGE OF UAHC HEALTH PLAN
OF TENNESSEE, INC.
SHAREHOLDER AGREEMENT]
IN WITNESS WHEREOF, this Agreement is executed by and among the parties
hereto on the dates set forth opposite their signatures below.
SHAREHOLDERS:
"UAHC"
UNITED AMERICAN OF TENNESSEE, INC.
Date: By:
------------------------ ------------------------------------
Its:
-----------------------------------
"MHI"
MOLINA HEALTHCARE, INC.
Date: By:
------------------------ ------------------------------------
Its:
-----------------------------------
CORPORATION:
UAHC HEALTH PLAN OF TENNESSEE, INC.
Date: By:
------------------------ ------------------------------------
Its:
-----------------------------------
11
EXHIBIT "1"
GOVERNANCE PROVISIONS
CONTINGENT GOVERNANCE PROVISIONS
1.1 BOARD OF DIRECTORS. The Corporation's Board of Directors (the "Board")
shall have twelve (12) authorized members. MHI and UAHC shall elect board
members in proportion to their ownership interests.
1.2 MATTERS REQUIRING UNANIMOUS APPROVAL OF THE BOARD. In addition to such
other matters as may be required or permitted by law, the following matters
shall require the unanimous approval of the Board:
(a) other than in the ordinary course of business, expending more than
$100,000 in any transaction or series of related transactions;
(b) entering into any employment contract that is not terminable at
will;
(c) adopting an annual capital and operating budget for the
Corporation (the "Annual Budget"), which shall include the Corporation's
staffing plans for such annual period;
(d) leasing any real or personal property, other than in the ordinary
course of business or except as provided for in the Annual Budget;
(e) borrowing any money or property or otherwise obtaining financing
for the Corporation, other than credit purchases of goods and services on a
current basis and in the normal course of business;
(f) causing the Corporation to guarantee or act as surety for the debt
or obligation of any person;
(g) organizing, acquiring or disposing of an interest in, merging or
combining with, or entering into a corporation, partnership or joint venture
with any other person or entity;
(h) issuing Shares to any person;
(i) entering into, or modifying, any agreements with Affiliates;
(j) selling or otherwise disposing of all or substantially all of the
assets or business of the Corporation.
12
(UNITED AMERICAN HEALTHCARE CORPORATION LOGO)
Using a BLACK INK pen, mark your votes with an X as shown in this example.
Please do not write outside the designated areas. [X]
ANNUAL MEETING PROXY CARD - UNITED AMERICAN HEALTHCARE CORPORATION
PLEASE FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE
ENCLOSED ENVELOPE.
A PROPOSALS -- THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR PROPOSAL 1.
For Against Abstain
--- ------- -------
1. To approve the Purchase Agreement dated [ ] [ ] [ ] 2. In their discretion, the Proxies are
as of March 24, 2008 among United American authorized to vote on such other
Healthcare Corporation, United American of business as may properly come before
Tennessee, Inc., UAHC Health Plan of the meeting.
Tennessee, Inc. and Molina Healthcare, Inc.
and all transactions contemplated therein.
B NON-VOTING ITEMS
CHANGE OF ADDRESS -- Please print your new address below.
C AUTHORIZED SIGNATURES -- THIS SECTION MUST BE COMPLETED FOR YOUR VOTE TO BE
COUNTED. -- DATE AND SIGN BELOW
NOTE: Please sign your name(s) EXACTLY as your name(s) appear(s) on this proxy.
All joint holders must sign. When signing as attorney, trustee, executor,
administrator, guardian or corporate officer, please provide your FULL title.
Date (mm/dd/yyyy) - Signature 1 - Please keep Signature 2 - Please keep
Please print date below. signature within the box signature within the box
------------------------ ------------------------- -------------------------
PLEASE FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE
ENCLOSED ENVELOPE.
(UNITED AMERICAN HEALTHCARE CORPORATION LOGO)
PROXY -- UNITED AMERICAN HEALTHCARE CORPORATION
PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
SPECIAL MEETING OF SHAREHOLDERS
_____, 2008
The undersigned appoints William C. Brooks and Stephen D. Harris and each of
them, as Proxies, with full power of substitution, to attend the Special Meeting
of Shareholders of United American Healthcare Corporation on _____, 2008, and
any adjournments, and to represent and vote the shares which the undersigned is
entitled to vote on the following matters as directed on the reverse side.
When properly executed, these instructions will be voted in the manner directed
on the reverse side of this card; if you do not provide direction, this proxy
will be voted FOR Item 1.
YOUR VOTE IS IMPORTANT!
PLEASE VOTE, SIGN, DATE AND RETURN THIS PROXY CARD PROMPTLY USING THE ENCLOSED
ENVELOPE.
(SEE REVERSE SIDE)